##GENOME_BUILD=GRCh38
##CREATION_DATE=2021-10-28
##ANALYSISTYPE=GERMLINE_SINGLESAMPLE
##PIPELINE=megSAP 0.2-737-g95016884
##SAMPLE=<ID=NA12878_03,Gender=female,ExternalSampleName=Coriell-DNA,IsTumor=no,IsFFPE=no,DiseaseGroup=Neoplasms,DiseaseStatus=affected>
##FILTER=off-target=Variant marked as 'off-target'.
##FILTER=low_conf_region=Variant marked as 'low_conf_region'.
##DESCRIPTION=NA12878_03=Genotype of variant in sample.
##DESCRIPTION=filter=Annotations for filtering and ranking variants.
##DESCRIPTION=quality=Quality parameters - variant quality (QUAL), depth (DP), allele frequency (AF), mean mapping quality of alternate allele (MQM), probability of strand bias for alternate bases as phred score (SAP), probability of allele ballance as phred score (ABP)
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, ENST number, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=coding_and_splicing_refseq=Coding and splicing details based on RefSeq (Gene, RefSeq id, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=regulatory=Regulatory consequence details.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=1000g=Allele frequency in 1000 genomes project.
##DESCRIPTION=gnomAD=Allele frequency in gnomAD project.
##DESCRIPTION=gnomAD_hom_hemi=Homoyzgous counts and hemizygous counts of gnomAD project (genome data).
##DESCRIPTION=gnomAD_sub=Sub-population allele frequenciens (AFR,AMR,EAS,NFE,SAS) in gnomAD project.
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=Sift=Sift effect prediction and score for each transcript: D=damaging, T=tolerated.
##DESCRIPTION=PolyPhen=PolyPhen (humVar) effect prediction and score for each transcript: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=CADD=CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 10-20.
##DESCRIPTION=REVEL=REVEL pathogenicity prediction score. Deleterious threshold > 0.5.
##DESCRIPTION=MaxEntScan=MaxEntScan splicing prediction (reference bases score/alternate bases score).
##DESCRIPTION=dbscSNV=dbscSNV splicing prediction (ADA/RF score).
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=MMSplice_DeltaLogitPSI=MMsplice delta Logit PSI score: variant's effect on the exon inclusion - positive score shows higher exon inclusion, negative higher exclusion rate. A score greater than 2 or less than -2 can be considered strong.
##DESCRIPTION=MMSplice_pathogenicity=MMsplice pathogenicity score: probability of pathogenic effect of the variant on splicing
##DESCRIPTION=SpliceAI=SpliceAI prediction of splice-site variations. Probability of the variant being splice-altering (range from 0-1). The score is the maximum value of acceptor/donor gain/loss of all effected genes.
##DESCRIPTION=NGSD_hom=Homozygous variant count in NGSD.
##DESCRIPTION=NGSD_het=Heterozygous variant count in NGSD.
##DESCRIPTION=NGSD_group=Homozygous / heterozygous variant count in NGSD with the same disease group.
##DESCRIPTION=classification=Classification from the NGSD.
##DESCRIPTION=classification_comment=Classification comment from the NGSD.
##DESCRIPTION=validation=Validation information from the NGSD. Validation results of other samples are listed in brackets!
##DESCRIPTION=comment=Variant comments from the NGSD.
##DESCRIPTION=gene_info=Gene information from NGSD (inheritance mode, gnomAD o/e scores).
##FILTER=low_conf_region=Low confidence region for small variant calling based on gnomAD AC0/RF filters and IMGAG trio/twin data.
#chr	start	end	ref	obs	NA12878_03	filter	quality	gene	variant_type	coding_and_splicing	coding_and_splicing_refseq	regulatory	OMIM	ClinVar	HGMD	RepeatMasker	dbSNP	1000g	gnomAD	gnomAD_hom_hemi	gnomAD_sub	phyloP	Sift	PolyPhen	CADD	REVEL	MaxEntScan	dbscSNV	COSMIC	MMSplice_DeltaLogitPSI	MMSplice_pathogenicity	SpliceAI	NGSD_hom	NGSD_het	NGSD_group	classification	classification_comment	validation	comment	gene_info
chr1	27355990	27355990	G	A	het	off-target	QUAL=2185;DP=168;AF=0.51;MQM=60;SAP=15;ABP=3	MAP3K6	intron	MAP3K6:ENST00000357582.3:intron_variant:MODIFIER:intron27/28:c.3711+36C>T::,MAP3K6:ENST00000374040.7:intron_variant:MODIFIER:intron26/27:c.3687+36C>T::	MAP3K6:NM_001297609.2:intron_variant:MODIFIER:intron26/27:c.3687+36C>T::,MAP3K6:NM_004672.5:intron_variant:MODIFIER:intron27/28:c.3711+36C>T::,MAP3K6:XM_017002771.1:intron_variant:MODIFIER:intron25/26:c.2454+36C>T::,MAP3K6:XR_946795.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron27/28:n.5158+36C>T::						rs12569127	0.1903	0.2714	5878,.	0.2161,0.2029,0.1156,0.3237,0.1645	-0.4890			0.35				COSV58872155	0.002	0.1439	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SYTL1 (inh=n/a oe_syn=0.98 oe_mis=0.79 oe_lof=0.73), MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58)
chr1	27359572	27359572	G	C	hom	off-target	QUAL=6130;DP=198;AF=1.00;MQM=60;SAP=5;ABP=0	MAP3K6	intron	MAP3K6:ENST00000357582.3:intron_variant:MODIFIER:intron17/28:c.2320-50C>G::,MAP3K6:ENST00000374040.7:intron_variant:MODIFIER:intron16/27:c.2296-50C>G::	MAP3K6:NM_001297609.2:intron_variant:MODIFIER:intron16/27:c.2296-50C>G::,MAP3K6:NM_004672.5:intron_variant:MODIFIER:intron17/28:c.2320-50C>G::,MAP3K6:XM_017002771.1:intron_variant:MODIFIER:intron15/26:c.1063-50C>G::,MAP3K6:XM_017002772.1:intron_variant:MODIFIER:intron17/17:c.2320-13C>G::,MAP3K6:XR_946794.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron17/24:n.3751-50C>G::,MAP3K6:XR_946795.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron17/28:n.3750-50C>G::						rs7521552		0.9943	74221,.	0.9655,0.9966,1.0000,0.9953,0.9965	-0.1950			3.40					-0.0295	0.1433	0.79	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58)
chr1	27360975	27360975	G	T	het		QUAL=9721;DP=729;AF=0.52;MQM=60;SAP=4;ABP=5	MAP3K6	missense	MAP3K6:ENST00000357582.3:missense_variant:MODERATE:exon14/29:c.1866C>A:p.Asn622Lys:,MAP3K6:ENST00000374040.7:missense_variant:MODERATE:exon13/28:c.1842C>A:p.Asn614Lys:	MAP3K6:NM_001297609.2:missense_variant:MODERATE:exon13/28:c.1842C>A:p.Asn614Lys:,MAP3K6:NM_004672.5:missense_variant:MODERATE:exon14/29:c.1866C>A:p.Asn622Lys:,MAP3K6:XM_017002771.1:missense_variant:MODERATE:exon12/27:c.609C>A:p.Asn203Lys:,MAP3K6:XM_017002772.1:missense_variant:MODERATE:exon14/18:c.1866C>A:p.Asn622Lys:,MAP3K6:XR_946794.3:non_coding_transcript_exon_variant:MODIFIER:exon14/25:n.3297C>A::,MAP3K6:XR_946795.3:non_coding_transcript_exon_variant:MODIFIER:exon14/29:n.3296C>A::	regulatory_region_variant:promoter		403071 [benign DISEASE=not specified];			rs35659744	0.1220	0.2260	4303,.	0.0497,0.1399,0.0936,0.3028,0.1508	0.1830	T(0.18),T(0.20)	B(0.00),B(0.00)	13.87	0.04			COSV62887042,COSV62889375	0.1192	0.1097	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58)
chr1	27363868	27363868	T	C	het	off-target	QUAL=1451;DP=111;AF=0.53;MQM=60;SAP=4;ABP=4	MAP3K6	intron	MAP3K6:ENST00000357582.3:intron_variant:MODIFIER:intron5/28:c.864+49A>G::,MAP3K6:ENST00000374040.7:intron_variant:MODIFIER:intron4/27:c.840+49A>G::	MAP3K6:NM_001297609.2:intron_variant:MODIFIER:intron4/27:c.840+49A>G::,MAP3K6:NM_004672.5:intron_variant:MODIFIER:intron5/28:c.864+49A>G::,MAP3K6:XM_017002771.1:intron_variant:MODIFIER:intron3/26:c.-406+49A>G::,MAP3K6:XM_017002772.1:intron_variant:MODIFIER:intron5/17:c.864+49A>G::,MAP3K6:XR_946794.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/24:n.2295+49A>G::,MAP3K6:XR_946795.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/28:n.2294+49A>G::					MIRb (SINE/MIR)	rs4307592	0.2196	0.3044	7286,.	0.3199,0.2199,0.1139,0.3232,0.1662	-0.0450			5.97				COSV62890059	0.0319	0.2915	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58)
chr1	27364153	27364153	A	G	het	off-target	QUAL=639;DP=88;AF=0.35;MQM=60;SAP=4;ABP=20	MAP3K6	intron	MAP3K6:ENST00000357582.3:intron_variant:MODIFIER:intron4/28:c.695+51T>C::,MAP3K6:ENST00000374040.7:intron_variant:MODIFIER:intron3/27:c.671+51T>C::	MAP3K6:NM_001297609.2:intron_variant:MODIFIER:intron3/27:c.671+51T>C::,MAP3K6:NM_004672.5:intron_variant:MODIFIER:intron4/28:c.695+51T>C::,MAP3K6:XM_017002771.1:intron_variant:MODIFIER:intron2/26:c.-575+51T>C::,MAP3K6:XM_017002772.1:intron_variant:MODIFIER:intron4/17:c.695+51T>C::,MAP3K6:XR_946794.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/24:n.2126+51T>C::,MAP3K6:XR_946795.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/28:n.2125+51T>C::		604973_[GENE=FCN3_PHENOS=Immunodeficiency due to ficolin 3 deficiency, 613860 (3), Autosomal recessive]				rs12727507	0.3548	0.4246	15760,.	0.6804,0.2466,0.1147,0.3568,0.1999	0.0210			3.13				COSV54641801	-0.0365	0.3088	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58), FCN3 (inh=AR oe_syn=0.74 oe_mis=0.91 oe_lof=0.45)
chr1	45330597	45330597	G	C	hom	off-target	QUAL=264;DP=10;AF=1.00;MQM=60;SAP=25;ABP=0	MUTYH,	intron,intron&NMD_transcript	MUTYH:ENST00000354383.10:intron_variant:MODIFIER:intron14/15:c.1396-40C>G::,MUTYH:ENST00000355498.6:intron_variant:MODIFIER:intron14/15:c.1393-40C>G::,MUTYH:ENST00000372098.7:intron_variant:MODIFIER:intron14/15:c.1468-40C>G::,MUTYH:ENST00000372104.5:intron_variant:MODIFIER:intron15/16:c.1393-40C>G::,MUTYH:ENST00000372110.7:intron_variant:MODIFIER:intron14/15:c.1438-40C>G::,MUTYH:ENST00000372115.7:intron_variant:MODIFIER:intron14/15:c.1435-40C>G::,MUTYH:ENST00000448481.5:intron_variant:MODIFIER:intron14/15:c.1426-40C>G::,MUTYH:ENST00000456914.7:intron_variant:MODIFIER:intron14/15:c.1393-40C>G::,MUTYH:ENST00000488731.6:intron_variant:MODIFIER:intron5/6:c.478-40C>G::,MUTYH:ENST00000528013.6:intron_variant:MODIFIER:intron14/15:c.1435-40C>G::,MUTYH:ENST00000529984.5:intron_variant:MODIFIER:intron5/6:c.478-40C>G::,MUTYH:ENST00000531105.5:intron_variant:MODIFIER:intron2/2:c.116-1160C>G::,:ENST00000671898.1:intron_variant&NMD_transcript_variant:MODIFIER:intron18/20:c.1981-40C>G::,MUTYH:ENST00000672818.3:intron_variant:MODIFIER:intron14/15:c.1468-40C>G::	MUTYH:NM_001048171.2:intron_variant:MODIFIER:intron14/15:c.1393-40C>G::,MUTYH:NM_001048172.2:intron_variant:MODIFIER:intron14/15:c.1396-40C>G::,MUTYH:NM_001048173.2:intron_variant:MODIFIER:intron14/15:c.1393-40C>G::,MUTYH:NM_001048174.2:intron_variant:MODIFIER:intron14/15:c.1393-40C>G::,MUTYH:NM_001128425.2:intron_variant:MODIFIER:intron14/15:c.1477-40C>G::,MUTYH:NM_001293190.2:intron_variant:MODIFIER:intron14/15:c.1438-40C>G::,MUTYH:NM_001293191.2:intron_variant:MODIFIER:intron14/15:c.1426-40C>G::,MUTYH:NM_001293192.2:intron_variant:MODIFIER:intron14/15:c.1117-40C>G::,MUTYH:NM_001293195.2:intron_variant:MODIFIER:intron15/16:c.1393-40C>G::,MUTYH:NM_001293196.2:intron_variant:MODIFIER:intron14/15:c.1117-40C>G::,MUTYH:NM_001350650.2:intron_variant:MODIFIER:intron13/14:c.1048-40C>G::,MUTYH:NM_001350651.2:intron_variant:MODIFIER:intron13/14:c.1048-40C>G::,MUTYH:NM_012222.3:intron_variant:MODIFIER:intron14/15:c.1468-40C>G::,MUTYH:NR_146882.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron14/16:n.1621-40C>G::,MUTYH:NR_146883.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron13/15:n.1470-40C>G::,MUTYH:XM_011541497.3:intron_variant:MODIFIER:intron14/15:c.1453-40C>G::,MUTYH:XM_011541498.1:intron_variant:MODIFIER:intron14/15:c.1435-40C>G::,MUTYH:XM_011541499.1:intron_variant:MODIFIER:intron14/15:c.1435-40C>G::,MUTYH:XM_011541500.3:intron_variant:MODIFIER:intron14/15:c.1435-40C>G::,MUTYH:XM_011541501.2:intron_variant:MODIFIER:intron15/16:c.1435-40C>G::,MUTYH:XM_011541502.2:intron_variant:MODIFIER:intron14/15:c.1435-40C>G::,MUTYH:XM_011541503.2:intron_variant:MODIFIER:intron13/14:c.1435-40C>G::,MUTYH:XM_011541504.2:intron_variant:MODIFIER:intron14/15:c.1426-40C>G::,MUTYH:XM_011541505.2:intron_variant:MODIFIER:intron10/11:c.1015-40C>G::,MUTYH:XM_011541506.2:intron_variant:MODIFIER:intron10/11:c.1015-40C>G::,MUTYH:XM_017001331.1:intron_variant:MODIFIER:intron14/15:c.1435-40C>G::,MUTYH:XM_017001332.1:intron_variant:MODIFIER:intron14/15:c.1435-40C>G::,MUTYH:XM_017001333.1:intron_variant:MODIFIER:intron14/15:c.1435-40C>G::,MUTYH:XM_017001334.1:intron_variant:MODIFIER:intron14/15:c.1396-40C>G::,MUTYH:XM_017001335.1:intron_variant:MODIFIER:intron14/15:c.1117-40C>G::,MUTYH:XM_017001336.1:intron_variant:MODIFIER:intron13/14:c.1048-40C>G::,MUTYH:XM_017001337.1:intron_variant:MODIFIER:intron13/14:c.1048-40C>G::,MUTYH:XM_024447244.1:intron_variant:MODIFIER:intron13/14:c.1048-40C>G::,MUTYH:XM_024447245.1:intron_variant:MODIFIER:intron13/14:c.1048-40C>G::,MUTYH:XM_024447248.1:intron_variant:MODIFIER:intron12/13:c.1006-40C>G::,MUTYH:XM_024447249.1:intron_variant:MODIFIER:intron12/13:c.877-40C>G::,MUTYH:XM_024447250.1:intron_variant:MODIFIER:intron12/13:c.877-40C>G::,MUTYH:XM_024447251.1:intron_variant:MODIFIER:intron12/13:c.877-40C>G::,MUTYH:XR_001737190.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron14/16:n.1438-40C>G::,MUTYH:XR_001737192.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron12/14:n.1250-40C>G::,MUTYH:XR_002956643.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron12/14:n.1430-40C>G::,MUTYH:XR_002956644.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron11/13:n.1965-40C>G::,MUTYH:XR_946658.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron14/16:n.1538-40C>G::		618994_[GENE=HPDL_PHENOS=Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities, 619026 (3), Autosomal recessive; Spastic paraplegia 83, autosomal recessive, 619027 (3), Autosomal recessive]&604933_[GENE=MUTYH_PHENOS=Adenomas, multiple colorectal, 608456 (3), Autosomal recessive; Gastric cancer, somatic, 613659 (3)]	439920 [benign DISEASE=none provided,not provided];			rs3219493		0.9295	65830,.	0.9591,0.9512,0.8911,0.9120,0.9177	0.2630			4.74					0.0398	0.0368	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HPDL (inh=AR oe_syn=0.86 oe_mis=0.83 oe_lof=0.80), MUTYH (inh=AR oe_syn=1.01 oe_mis=1.03 oe_lof=0.88)
chr1	45331833	45331833	C	G	het		QUAL=3110;DP=231;AF=0.51;MQM=60;SAP=5;ABP=3	MUTYH,	missense,intron,missense&NMD_transcript	MUTYH:ENST00000354383.10:missense_variant:MODERATE:exon12/16:c.933G>C:p.Gln311His:,MUTYH:ENST00000355498.6:missense_variant:MODERATE:exon12/16:c.930G>C:p.Gln310His:,MUTYH:ENST00000372098.7:missense_variant:MODERATE:exon12/16:c.1005G>C:p.Gln335His:,MUTYH:ENST00000372104.5:missense_variant:MODERATE:exon13/17:c.930G>C:p.Gln310His:,MUTYH:ENST00000372110.7:missense_variant:MODERATE:exon12/16:c.975G>C:p.Gln325His:,MUTYH:ENST00000372115.7:missense_variant:MODERATE:exon12/16:c.972G>C:p.Gln324His:,MUTYH:ENST00000448481.5:missense_variant:MODERATE:exon12/16:c.963G>C:p.Gln321His:,MUTYH:ENST00000456914.7:missense_variant:MODERATE:exon12/16:c.930G>C:p.Gln310His:,MUTYH:ENST00000488731.6:intron_variant:MODIFIER:intron3/6:c.188-277G>C::,MUTYH:ENST00000528013.6:missense_variant:MODERATE:exon12/16:c.972G>C:p.Gln324His:,MUTYH:ENST00000529984.5:intron_variant:MODIFIER:intron3/6:c.188-277G>C::,MUTYH:ENST00000531105.5:intron_variant:MODIFIER:intron2/2:c.116-2396G>C::,:ENST00000671898.1:missense_variant&NMD_transcript_variant:MODERATE:exon16/21:c.1518G>C:p.Gln506His:,MUTYH:ENST00000672818.3:missense_variant:MODERATE:exon12/16:c.1005G>C:p.Gln335His:	MUTYH:NM_001048171.2:missense_variant:MODERATE:exon12/16:c.930G>C:p.Gln310His:,MUTYH:NM_001048172.2:missense_variant:MODERATE:exon12/16:c.933G>C:p.Gln311His:,MUTYH:NM_001048173.2:missense_variant:MODERATE:exon12/16:c.930G>C:p.Gln310His:,MUTYH:NM_001048174.2:missense_variant:MODERATE:exon12/16:c.930G>C:p.Gln310His:,MUTYH:NM_001128425.2:missense_variant:MODERATE:exon12/16:c.1014G>C:p.Gln338His:,MUTYH:NM_001293190.2:missense_variant:MODERATE:exon12/16:c.975G>C:p.Gln325His:,MUTYH:NM_001293191.2:missense_variant:MODERATE:exon12/16:c.963G>C:p.Gln321His:,MUTYH:NM_001293192.2:missense_variant:MODERATE:exon12/16:c.654G>C:p.Gln218His:,MUTYH:NM_001293195.2:missense_variant:MODERATE:exon13/17:c.930G>C:p.Gln310His:,MUTYH:NM_001293196.2:missense_variant:MODERATE:exon12/16:c.654G>C:p.Gln218His:,MUTYH:NM_001350650.2:missense_variant:MODERATE:exon11/15:c.585G>C:p.Gln195His:,MUTYH:NM_001350651.2:missense_variant:MODERATE:exon11/15:c.585G>C:p.Gln195His:,MUTYH:NM_012222.3:missense_variant:MODERATE:exon12/16:c.1005G>C:p.Gln335His:,MUTYH:NR_146882.2:non_coding_transcript_exon_variant:MODIFIER:exon12/17:n.1158G>C::,MUTYH:NR_146883.2:non_coding_transcript_exon_variant:MODIFIER:exon11/16:n.1007G>C::,MUTYH:XM_011541497.3:missense_variant:MODERATE:exon12/16:c.990G>C:p.Gln330His:,MUTYH:XM_011541498.1:missense_variant:MODERATE:exon12/16:c.972G>C:p.Gln324His:,MUTYH:XM_011541499.1:missense_variant:MODERATE:exon12/16:c.972G>C:p.Gln324His:,MUTYH:XM_011541500.3:missense_variant:MODERATE:exon12/16:c.972G>C:p.Gln324His:,MUTYH:XM_011541501.2:missense_variant:MODERATE:exon13/17:c.972G>C:p.Gln324His:,MUTYH:XM_011541502.2:missense_variant:MODERATE:exon12/16:c.972G>C:p.Gln324His:,MUTYH:XM_011541503.2:missense_variant:MODERATE:exon11/15:c.972G>C:p.Gln324His:,MUTYH:XM_011541504.2:missense_variant:MODERATE:exon12/16:c.963G>C:p.Gln321His:,MUTYH:XM_011541505.2:missense_variant:MODERATE:exon8/12:c.552G>C:p.Gln184His:,MUTYH:XM_011541506.2:missense_variant:MODERATE:exon8/12:c.552G>C:p.Gln184His:,MUTYH:XM_017001331.1:missense_variant:MODERATE:exon12/16:c.972G>C:p.Gln324His:,MUTYH:XM_017001332.1:missense_variant:MODERATE:exon12/16:c.972G>C:p.Gln324His:,MUTYH:XM_017001333.1:missense_variant:MODERATE:exon12/16:c.972G>C:p.Gln324His:,MUTYH:XM_017001334.1:missense_variant:MODERATE:exon12/16:c.933G>C:p.Gln311His:,MUTYH:XM_017001335.1:missense_variant:MODERATE:exon12/16:c.654G>C:p.Gln218His:,MUTYH:XM_017001336.1:missense_variant:MODERATE:exon11/15:c.585G>C:p.Gln195His:,MUTYH:XM_017001337.1:missense_variant:MODERATE:exon11/15:c.585G>C:p.Gln195His:,MUTYH:XM_024447244.1:missense_variant:MODERATE:exon11/15:c.585G>C:p.Gln195His:,MUTYH:XM_024447245.1:missense_variant:MODERATE:exon11/15:c.585G>C:p.Gln195His:,MUTYH:XM_024447248.1:missense_variant:MODERATE:exon10/14:c.543G>C:p.Gln181His:,MUTYH:XM_024447249.1:missense_variant:MODERATE:exon10/14:c.414G>C:p.Gln138His:,MUTYH:XM_024447250.1:missense_variant:MODERATE:exon10/14:c.414G>C:p.Gln138His:,MUTYH:XM_024447251.1:missense_variant:MODERATE:exon10/14:c.414G>C:p.Gln138His:,MUTYH:XR_001737190.1:non_coding_transcript_exon_variant:MODIFIER:exon12/17:n.975G>C::,MUTYH:XR_001737192.1:non_coding_transcript_exon_variant:MODIFIER:exon10/15:n.787G>C::,MUTYH:XR_002956643.1:non_coding_transcript_exon_variant:MODIFIER:exon10/15:n.967G>C::,MUTYH:XR_002956644.1:non_coding_transcript_exon_variant:MODIFIER:exon9/14:n.1502G>C::,MUTYH:XR_946658.2:non_coding_transcript_exon_variant:MODIFIER:exon12/17:n.1075G>C::		618994_[GENE=HPDL_PHENOS=Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities, 619026 (3), Autosomal recessive; Spastic paraplegia 83, autosomal recessive, 619027 (3), Autosomal recessive]&604933_[GENE=MUTYH_PHENOS=Adenomas, multiple colorectal, 608456 (3), Autosomal recessive; Gastric cancer, somatic, 613659 (3)]	41767 [benign DISEASE=Carcinoma of colon,MYH-associated polyposis,Hereditary cancer-predisposing syndrome,Familial multiple polyposis syndrome,not specified,none provided,not provided];	CM083726 [CLASS=DFP MUT=ALT PHEN="Reduced activity" GENE=MUTYH];		rs3219489	0.3135	0.2900	5824,.	0.2630,0.4881,0.3974,0.2444,0.2371	-0.2650	T(0.10),T(0.10),T(0.08),T(0.10),T(0.09),T(0.08),T(0.09),T(0.10), ,T(0.08), , ,T(0.09),T(0.08)	B(0.15),B(0.21),B(0.29),B(0.21),B(0.38),B(0.21),B(0.29),B(0.21), ,B(0.21), , ,P(0.90),B(0.29)	8.88	0.04			COSV58343790	0.0714	0.9516	0.06	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HPDL (inh=AR oe_syn=0.86 oe_mis=0.83 oe_lof=0.80), MUTYH (inh=AR oe_syn=1.01 oe_mis=1.03 oe_lof=0.88)
chr1	45332883	45332883	T	C	hom	off-target	QUAL=5838;DP=189;AF=1.00;MQM=60;SAP=3;ABP=0	MUTYH,	intron,intron&NMD_transcript	MUTYH:ENST00000354383.10:intron_variant:MODIFIER:intron6/15:c.423+35A>G::,MUTYH:ENST00000355498.6:intron_variant:MODIFIER:intron6/15:c.420+35A>G::,MUTYH:ENST00000372098.7:intron_variant:MODIFIER:intron6/15:c.495+35A>G::,MUTYH:ENST00000372104.5:intron_variant:MODIFIER:intron7/16:c.420+35A>G::,MUTYH:ENST00000372110.7:intron_variant:MODIFIER:intron6/15:c.465+35A>G::,MUTYH:ENST00000372115.7:intron_variant:MODIFIER:intron6/15:c.462+35A>G::,MUTYH:ENST00000448481.5:intron_variant:MODIFIER:intron6/15:c.453+35A>G::,MUTYH:ENST00000456914.7:intron_variant:MODIFIER:intron6/15:c.420+35A>G::,MUTYH:ENST00000488731.6:intron_variant:MODIFIER:intron2/6:c.116-49A>G::,MUTYH:ENST00000528013.6:intron_variant:MODIFIER:intron6/15:c.462+35A>G::,MUTYH:ENST00000529984.5:intron_variant:MODIFIER:intron2/6:c.116-49A>G::,MUTYH:ENST00000531105.5:intron_variant:MODIFIER:intron2/2:c.115+1508A>G::,:ENST00000671898.1:intron_variant&NMD_transcript_variant:MODIFIER:intron10/20:c.1008+35A>G::,MUTYH:ENST00000672818.3:intron_variant:MODIFIER:intron6/15:c.495+35A>G::	MUTYH:NM_001048171.2:intron_variant:MODIFIER:intron6/15:c.420+35A>G::,MUTYH:NM_001048172.2:intron_variant:MODIFIER:intron6/15:c.423+35A>G::,MUTYH:NM_001048173.2:intron_variant:MODIFIER:intron6/15:c.420+35A>G::,MUTYH:NM_001048174.2:intron_variant:MODIFIER:intron6/15:c.420+35A>G::,MUTYH:NM_001128425.2:intron_variant:MODIFIER:intron6/15:c.504+35A>G::,MUTYH:NM_001293190.2:intron_variant:MODIFIER:intron6/15:c.465+35A>G::,MUTYH:NM_001293191.2:intron_variant:MODIFIER:intron6/15:c.453+35A>G::,MUTYH:NM_001293192.2:intron_variant:MODIFIER:intron6/15:c.144+35A>G::,MUTYH:NM_001293195.2:intron_variant:MODIFIER:intron7/16:c.420+35A>G::,MUTYH:NM_001293196.2:intron_variant:MODIFIER:intron6/15:c.144+35A>G::,MUTYH:NM_001350650.2:intron_variant:MODIFIER:intron5/14:c.75+35A>G::,MUTYH:NM_001350651.2:intron_variant:MODIFIER:intron5/14:c.75+35A>G::,MUTYH:NM_012222.3:intron_variant:MODIFIER:intron6/15:c.495+35A>G::,MUTYH:NR_146882.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/16:n.648+35A>G::,MUTYH:NR_146883.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/15:n.497+35A>G::,MUTYH:XM_011541497.3:intron_variant:MODIFIER:intron6/15:c.480+35A>G::,MUTYH:XM_011541498.1:intron_variant:MODIFIER:intron6/15:c.462+35A>G::,MUTYH:XM_011541499.1:intron_variant:MODIFIER:intron6/15:c.462+35A>G::,MUTYH:XM_011541500.3:intron_variant:MODIFIER:intron6/15:c.462+35A>G::,MUTYH:XM_011541501.2:intron_variant:MODIFIER:intron7/16:c.462+35A>G::,MUTYH:XM_011541502.2:intron_variant:MODIFIER:intron6/15:c.462+35A>G::,MUTYH:XM_011541503.2:intron_variant:MODIFIER:intron5/14:c.463-49A>G::,MUTYH:XM_011541504.2:intron_variant:MODIFIER:intron6/15:c.453+35A>G::,MUTYH:XM_011541505.2:intron_variant:MODIFIER:intron2/11:c.43-49A>G::,MUTYH:XM_011541506.2:intron_variant:MODIFIER:intron2/11:c.43-49A>G::,MUTYH:XM_017001331.1:intron_variant:MODIFIER:intron6/15:c.462+35A>G::,MUTYH:XM_017001332.1:intron_variant:MODIFIER:intron6/15:c.462+35A>G::,MUTYH:XM_017001333.1:intron_variant:MODIFIER:intron6/15:c.462+35A>G::,MUTYH:XM_017001334.1:intron_variant:MODIFIER:intron6/15:c.423+35A>G::,MUTYH:XM_017001335.1:intron_variant:MODIFIER:intron6/15:c.144+35A>G::,MUTYH:XM_017001336.1:intron_variant:MODIFIER:intron5/14:c.75+35A>G::,MUTYH:XM_017001337.1:intron_variant:MODIFIER:intron5/14:c.75+35A>G::,MUTYH:XM_024447244.1:intron_variant:MODIFIER:intron5/14:c.75+35A>G::,MUTYH:XM_024447245.1:intron_variant:MODIFIER:intron5/14:c.75+35A>G::,MUTYH:XM_024447248.1:intron_variant:MODIFIER:intron4/13:c.34-49A>G::,MUTYH:XM_024447249.1:intron_variant:MODIFIER:intron4/13:c.-97+35A>G::,MUTYH:XM_024447250.1:intron_variant:MODIFIER:intron4/13:c.-97+35A>G::,MUTYH:XM_024447251.1:5_prime_UTR_variant:MODIFIER:exon5/14:c.-145A>G::,MUTYH:XR_001737190.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/16:n.465+35A>G::,MUTYH:XR_001737192.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/14:n.278-49A>G::,MUTYH:XR_002956643.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/14:n.458-49A>G::,MUTYH:XR_002956644.1:non_coding_transcript_exon_variant:MODIFIER:exon4/14:n.944A>G::,MUTYH:XR_946658.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/16:n.565+35A>G::		618994_[GENE=HPDL_PHENOS=Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities, 619026 (3), Autosomal recessive; Spastic paraplegia 83, autosomal recessive, 619027 (3), Autosomal recessive]&604933_[GENE=MUTYH_PHENOS=Adenomas, multiple colorectal, 608456 (3), Autosomal recessive; Gastric cancer, somatic, 613659 (3)]	257529 [benign DISEASE=not specified,none provided,not provided];			rs3219487		0.9326	66268,.	0.9677,0.9530,0.8902,0.9134,0.9190	-1.2610			0.66				COSV58343750	0.1949	0.943	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HPDL (inh=AR oe_syn=0.86 oe_mis=0.83 oe_lof=0.80), MUTYH (inh=AR oe_syn=1.01 oe_mis=1.03 oe_lof=0.88)
chr1	62273526	62273526	G	A	het		QUAL=1755;DP=140;AF=0.49;MQM=60;SAP=10;ABP=3	KANK4	intron,synonymous	KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron2/8:c.17-1937C>T::,KANK4:ENST00000371153.9:synonymous_variant:LOW:exon3/10:c.1578C>T:p.Ser526=:	KANK4:NM_001320269.2:intron_variant:MODIFIER:intron2/8:c.17-1937C>T::,KANK4:NM_181712.5:synonymous_variant:LOW:exon3/10:c.1578C>T:p.Ser526=:,KANK4:XM_011540843.3:synonymous_variant:LOW:exon3/10:c.1578C>T:p.Ser526=:,KANK4:XM_011540845.3:synonymous_variant:LOW:exon3/10:c.1578C>T:p.Ser526=:,KANK4:XM_017000483.2:synonymous_variant:LOW:exon3/9:c.1578C>T:p.Ser526=:,KANK4:XM_017000484.2:intron_variant:MODIFIER:intron3/9:c.17-1937C>T::	regulatory_region_variant:promoter_flanking_region		1270734 [benign DISEASE=not provided];			rs17855078	0.2506	0.3037	6374,.	0.1791,0.2220,0.1264,0.3399,0.4044	-1.1030			0.19				COSV62990033	-0.0137	0.5258	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62274393	62274393	A	G	het		QUAL=1454;DP=128;AF=0.48;MQM=60;SAP=3;ABP=4	KANK4	intron,synonymous	KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron2/8:c.17-2804T>C::,KANK4:ENST00000371153.9:synonymous_variant:LOW:exon3/10:c.711T>C:p.Gly237=:	KANK4:NM_001320269.2:intron_variant:MODIFIER:intron2/8:c.17-2804T>C::,KANK4:NM_181712.5:synonymous_variant:LOW:exon3/10:c.711T>C:p.Gly237=:,KANK4:XM_011540843.3:synonymous_variant:LOW:exon3/10:c.711T>C:p.Gly237=:,KANK4:XM_011540845.3:synonymous_variant:LOW:exon3/10:c.711T>C:p.Gly237=:,KANK4:XM_017000483.2:synonymous_variant:LOW:exon3/9:c.711T>C:p.Gly237=:,KANK4:XM_017000484.2:intron_variant:MODIFIER:intron3/9:c.17-2804T>C::			1265023 [benign DISEASE=not provided];			rs12127930	0.4822	0.4810	18375,.	0.6174,0.3608,0.2619,0.4397,0.5676	-1.1560			0.28				COSV62986848	0.0154	0.5273	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62274774	62274774	T	C	hom		QUAL=7500;DP=239;AF=1.00;MQM=60;SAP=4;ABP=0	KANK4	intron,synonymous	KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron2/8:c.17-3185A>G::,KANK4:ENST00000371153.9:synonymous_variant:LOW:exon3/10:c.330A>G:p.Pro110=:	KANK4:NM_001320269.2:intron_variant:MODIFIER:intron2/8:c.17-3185A>G::,KANK4:NM_181712.5:synonymous_variant:LOW:exon3/10:c.330A>G:p.Pro110=:,KANK4:XM_011540843.3:synonymous_variant:LOW:exon3/10:c.330A>G:p.Pro110=:,KANK4:XM_011540845.3:synonymous_variant:LOW:exon3/10:c.330A>G:p.Pro110=:,KANK4:XM_017000483.2:synonymous_variant:LOW:exon3/9:c.330A>G:p.Pro110=:,KANK4:XM_017000484.2:intron_variant:MODIFIER:intron3/9:c.17-3185A>G::			1262658 [benign DISEASE=not provided];			rs2666506	0.8045	0.7557	43743,.	0.8578,0.8402,0.8658,0.6865,0.7418	-0.6950			3.59				COSV62988812	0.0056	0.5268	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62274777	62274777	T	C	hom		QUAL=7500;DP=239;AF=1.00;MQM=60;SAP=4;ABP=0	KANK4	intron,synonymous	KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron2/8:c.17-3188A>G::,KANK4:ENST00000371153.9:synonymous_variant:LOW:exon3/10:c.327A>G:p.Ser109=:	KANK4:NM_001320269.2:intron_variant:MODIFIER:intron2/8:c.17-3188A>G::,KANK4:NM_181712.5:synonymous_variant:LOW:exon3/10:c.327A>G:p.Ser109=:,KANK4:XM_011540843.3:synonymous_variant:LOW:exon3/10:c.327A>G:p.Ser109=:,KANK4:XM_011540845.3:synonymous_variant:LOW:exon3/10:c.327A>G:p.Ser109=:,KANK4:XM_017000483.2:synonymous_variant:LOW:exon3/9:c.327A>G:p.Ser109=:,KANK4:XM_017000484.2:intron_variant:MODIFIER:intron3/9:c.17-3188A>G::			1182584 [benign DISEASE=not provided];			rs2666507	0.7809	0.7418	40797,.	0.7750,0.8364,0.8658,0.6862,0.7416	-2.2680			0.25				COSV62988817	0.0049	0.5268	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62275109	62275109	A	-	het	off-target	QUAL=270;DP=116;AF=0.20;MQM=60;SAP=3;ABP=95	KANK4	intron	KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron2/8:c.17-3520del::,KANK4:ENST00000371153.9:intron_variant:MODIFIER:intron2/9:c.17-22del::	KANK4:NM_001320269.2:intron_variant:MODIFIER:intron2/8:c.17-3520del::,KANK4:NM_181712.5:intron_variant:MODIFIER:intron2/9:c.17-22del::,KANK4:XM_011540843.3:intron_variant:MODIFIER:intron2/9:c.17-22del::,KANK4:XM_011540845.3:intron_variant:MODIFIER:intron2/9:c.17-22del::,KANK4:XM_017000483.2:intron_variant:MODIFIER:intron2/8:c.17-22del::,KANK4:XM_017000484.2:intron_variant:MODIFIER:intron3/9:c.17-3520del::	regulatory_region_variant:open_chromatin_region					rs761923018		0.1206	0,.	0.0807,0.1653,0.1052,0.1096,0.1776	0.0400			2.59								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	78112493	78112493	T	C	het		QUAL=4981;DP=413;AF=0.46;MQM=60;SAP=4;ABP=10	GIPC2	intron	GIPC2:ENST00000370759.4:intron_variant:MODIFIER:intron3/5:c.608-6900T>C::	GIPC2:NM_001304725.2:intron_variant:MODIFIER:intron3/5:c.386-6900T>C::,GIPC2:NM_017655.6:intron_variant:MODIFIER:intron3/5:c.608-6900T>C::	regulatory_region_variant:open_chromatin_region					rs6666954	0.4489	0.3776	12754,.	0.6112,0.2545,0.6166,0.2758,0.2698	-1.1960			0.35				COSV66129252			0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GIPC2 (inh=n/a oe_syn=1.00 oe_mis=1.06 oe_lof=1.01)
chr1	119915381	119915381	A	T	het		QUAL=1766;DP=130;AF=0.55;MQM=60;SAP=3;ABP=6	NOTCH2	synonymous	NOTCH2:ENST00000256646.7:synonymous_variant:LOW:exon34/34:c.7341T>A:p.Gly2447=:	NOTCH2:NM_024408.4:synonymous_variant:LOW:exon34/34:c.7341T>A:p.Gly2447=:		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	261705 [benign DISEASE=Hajdu-Cheney syndrome,not specified,not provided];			rs6685892	0.1925	0.1680	2968,.	0.3365,0.0881,0.0295,0.1028,0.1890	-0.7840			5.31				COSV56683182	0.0062	0.8881	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119922762	119922762	C	T	het		QUAL=268;DP=563;AF=0.33;MQM=60;SAP=403;ABP=150	NOTCH2	missense	NOTCH2:ENST00000256646.7:missense_variant:MODERATE:exon27/34:c.4876G>A:p.Glu1626Lys:PF07684 [NOTCH protein]	NOTCH2:NM_024408.4:missense_variant:MODERATE:exon27/34:c.4876G>A:p.Glu1626Lys:		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]				rs1447900658		0.0000		0.0000,0.0000,0.0000,0.0000,0.0000	6.1530	D(0.00)	D(1.00)	31.00	0.48				-0.1306	0.9313	0.01	0	1	0 / 1					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119929234	119929234	C	T	het	off-target	QUAL=525;DP=29;AF=0.69;MQM=60;SAP=5;ABP=12	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron22/33:c.3656-22G>A::	NOTCH2:NM_024408.4:intron_variant:MODIFIER:intron22/33:c.3656-22G>A::		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1265981 [benign DISEASE=not provided];			rs2493392	0.1925	0.1677	2962,.	0.3357,0.0880,0.0295,0.1022,0.1892	0.4450			5.44				COSV56687338	-0.1364	0.187	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119987127	119987127	A	C	het	off-target	QUAL=11312;DP=921;AF=0.48;MQM=60;SAP=4;ABP=6	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron4/33:c.752-45T>G::,NOTCH2:ENST00000579475.7:intron_variant:MODIFIER:intron4/14:c.635-45T>G::	NOTCH2:NM_001200001.2:intron_variant:MODIFIER:intron4/21:c.752-45T>G::,NOTCH2:NM_024408.4:intron_variant:MODIFIER:intron4/33:c.752-45T>G::	regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant	600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1283883 [benign DISEASE=not provided];			rs2453040	0.1907	0.1652	2870,.	0.3302,0.0871,0.0299,0.1014,0.1877	-0.0060			3.93				COSV56686013	-0.0313	0.0716	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr2	17760156	17760156	T	G	hom	off-target	QUAL=1007;DP=33;AF=1.00;MQM=60;SAP=38;ABP=0	GEN1,SMC6	intron	GEN1:ENST00000317402.11:intron_variant:MODIFIER:intron2/13:c.161+52T>G::,GEN1:ENST00000381254.7:intron_variant:MODIFIER:intron2/13:c.161+52T>G::,SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-5-14205A>C::	GEN1:NM_001130009.3:intron_variant:MODIFIER:intron2/13:c.161+52T>G::,GEN1:NM_182625.5:intron_variant:MODIFIER:intron2/13:c.161+52T>G::,GEN1:XM_005262613.4:intron_variant:MODIFIER:intron2/13:c.161+52T>G::,GEN1:XM_006712005.3:intron_variant:MODIFIER:intron2/13:c.161+52T>G::,GEN1:XM_011532820.2:intron_variant:MODIFIER:intron2/13:c.161+52T>G::,GEN1:XM_011532821.2:intron_variant:MODIFIER:intron2/13:c.161+52T>G::,GEN1:XM_011532822.2:intron_variant:MODIFIER:intron2/13:c.161+52T>G::			1261547 [benign DISEASE=not provided];			rs2555072		0.6825	29355,.	0.4720,0.8154,0.9574,0.6213,0.8616	-0.5730			0.32					-0.042	0.5316	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17761508	17761508	T	A	hom		QUAL=3038;DP=92;AF=1.00;MQM=60;SAP=14;ABP=0	GEN1,SMC6	missense,intron	GEN1:ENST00000317402.11:missense_variant:MODERATE:exon3/14:c.274T>A:p.Ser92Thr:PF00752 [XPG N-terminal domain],GEN1:ENST00000381254.7:missense_variant:MODERATE:exon3/14:c.274T>A:p.Ser92Thr:PF00752 [XPG N-terminal domain],SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-5-15557A>T::	GEN1:NM_001130009.3:missense_variant:MODERATE:exon3/14:c.274T>A:p.Ser92Thr:,GEN1:NM_182625.5:missense_variant:MODERATE:exon3/14:c.274T>A:p.Ser92Thr:,GEN1:XM_005262613.4:missense_variant:MODERATE:exon3/14:c.274T>A:p.Ser92Thr:,GEN1:XM_006712005.3:missense_variant:MODERATE:exon3/14:c.274T>A:p.Ser92Thr:,GEN1:XM_011532820.2:missense_variant:MODERATE:exon3/14:c.274T>A:p.Ser92Thr:,GEN1:XM_011532821.2:missense_variant:MODERATE:exon3/14:c.274T>A:p.Ser92Thr:,GEN1:XM_011532822.2:missense_variant:MODERATE:exon3/14:c.274T>A:p.Ser92Thr:			1169875 [benign DISEASE=not provided];			rs1812152		0.7177	37688,.	0.7654,0.8383,0.9844,0.6243,0.8734	0.6630	T(0.36),T(0.36), 	B(0.00),B(0.00), 	9.80	0.03				0.0628	0.9187	0.09	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17772760	17772760	G	A	hom		QUAL=972;DP=30;AF=1.00;MQM=60;SAP=22;ABP=0	GEN1,SMC6	missense,intron	GEN1:ENST00000317402.11:missense_variant:MODERATE:exon8/14:c.929G>A:p.Ser310Asn:,GEN1:ENST00000381254.7:missense_variant:MODERATE:exon8/14:c.929G>A:p.Ser310Asn:,SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-6+15055C>T::	GEN1:NM_001130009.3:missense_variant:MODERATE:exon8/14:c.929G>A:p.Ser310Asn:,GEN1:NM_182625.5:missense_variant:MODERATE:exon8/14:c.929G>A:p.Ser310Asn:,GEN1:XM_005262613.4:missense_variant:MODERATE:exon8/14:c.929G>A:p.Ser310Asn:,GEN1:XM_006712005.3:missense_variant:MODERATE:exon8/14:c.929G>A:p.Ser310Asn:,GEN1:XM_011532820.2:missense_variant:MODERATE:exon8/14:c.929G>A:p.Ser310Asn:,GEN1:XM_011532821.2:missense_variant:MODERATE:exon8/14:c.929G>A:p.Ser310Asn:,GEN1:XM_011532822.2:missense_variant:MODERATE:exon8/14:c.929G>A:p.Ser310Asn:,LOC105373449:XR_939762.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/3:n.1418-8113C>T::			1169876 [benign DISEASE=not provided];			rs300175		0.9944	74046,.	0.9515,0.9973,0.9998,0.9999,0.9842	-2.3000	T(1.00),T(1.00), 	B(0.00),B(0.00), 	0.00	0.02				0.0986	0.3022	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17773154	17773154	C	G	hom	off-target	QUAL=3002;DP=93;AF=1.00;MQM=60;SAP=4;ABP=0	GEN1,SMC6	intron	GEN1:ENST00000317402.11:intron_variant:MODIFIER:intron9/13:c.990+22C>G::,GEN1:ENST00000381254.7:intron_variant:MODIFIER:intron9/13:c.990+22C>G::,SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-6+14661G>C::	GEN1:NM_001130009.3:intron_variant:MODIFIER:intron9/13:c.990+22C>G::,GEN1:NM_182625.5:intron_variant:MODIFIER:intron9/13:c.990+22C>G::,GEN1:XM_005262613.4:intron_variant:MODIFIER:intron9/13:c.990+22C>G::,GEN1:XM_006712005.3:intron_variant:MODIFIER:intron9/13:c.990+22C>G::,GEN1:XM_011532820.2:intron_variant:MODIFIER:intron9/13:c.990+22C>G::,GEN1:XM_011532821.2:intron_variant:MODIFIER:intron9/13:c.990+22C>G::,GEN1:XM_011532822.2:intron_variant:MODIFIER:intron9/13:c.990+22C>G::,LOC105373449:XR_939762.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/3:n.1418-8507G>C::			1276608 [benign DISEASE=not provided];			rs300177		0.7167	37402,.	0.7561,0.8376,0.9847,0.6241,0.8732	-2.1750			0.06					-0.0804	0.3192	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17781183	17781183	A	G	hom		QUAL=3083;DP=96;AF=1.00;MQM=60;SAP=84;ABP=0	GEN1,SMC6	synonymous,intron	GEN1:ENST00000317402.11:synonymous_variant:LOW:exon14/14:c.1971A>G:p.Glu657=:,GEN1:ENST00000381254.7:synonymous_variant:LOW:exon14/14:c.1971A>G:p.Glu657=:,SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-6+6632T>C::	GEN1:NM_001130009.3:synonymous_variant:LOW:exon14/14:c.1971A>G:p.Glu657=:,GEN1:NM_182625.5:synonymous_variant:LOW:exon14/14:c.1971A>G:p.Glu657=:,GEN1:XM_005262613.4:synonymous_variant:LOW:exon14/14:c.1971A>G:p.Glu657=:,GEN1:XM_006712005.3:synonymous_variant:LOW:exon14/14:c.1971A>G:p.Glu657=:,GEN1:XM_011532820.2:synonymous_variant:LOW:exon14/14:c.1971A>G:p.Glu657=:,GEN1:XM_011532821.2:synonymous_variant:LOW:exon14/14:c.1971A>G:p.Glu657=:,GEN1:XM_011532822.2:synonymous_variant:LOW:exon14/14:c.1971A>G:p.Glu657=:,LOC105373449:XR_939762.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/3:n.1418-16536T>C::			1169877 [benign DISEASE=not provided];			rs300168		0.5891	19073,.	0.2165,0.7466,0.9232,0.5153,0.7680	0.7070			6.44				COSV58057416	-0.0013	0.8753	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17781251	17781251	C	T	hom		QUAL=3598;DP=112;AF=1.00;MQM=60;SAP=3;ABP=0	GEN1,SMC6	missense,intron	GEN1:ENST00000317402.11:missense_variant:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile:,GEN1:ENST00000381254.7:missense_variant:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile:,SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-6+6564G>A::	GEN1:NM_001130009.3:missense_variant:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile:,GEN1:NM_182625.5:missense_variant:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile:,GEN1:XM_005262613.4:missense_variant:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile:,GEN1:XM_006712005.3:missense_variant:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile:,GEN1:XM_011532820.2:missense_variant:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile:,GEN1:XM_011532821.2:missense_variant:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile:,GEN1:XM_011532822.2:missense_variant:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile:,LOC105373449:XR_939762.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/3:n.1418-16604G>A::			1169878 [benign DISEASE=not provided];			rs300169		0.7049	32838,.	0.5958,0.8273,0.9846,0.6234,0.8730	0.1650	T(1.00),T(1.00), 	B(0.00),B(0.00), 	4.92	0.05				-0.0058	0.8752	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	47373967	47373967	T	C	het		QUAL=747;DP=42;AF=0.71;MQM=60;SAP=3;ABP=20	EPCAM	missense	EPCAM:ENST00000263735.9:missense_variant:MODERATE:exon3/9:c.344T>C:p.Met115Thr:PF00086 [Thyroglobulin type-1 repeat],EPCAM:ENST00000405271.5:missense_variant:MODERATE:exon4/10:c.428T>C:p.Met143Thr:PF00086 [Thyroglobulin type-1 repeat]	EPCAM:NM_002354.3:missense_variant:MODERATE:exon3/9:c.344T>C:p.Met115Thr:	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	185535_[GENE=EPCAM_PHENOS=Colorectal cancer, hereditary nonpolyposis, type 8, 613244 (3); Diarrhea 5, with tufting enteropathy, congenital, 613217 (3), Autosomal recessive]	183700 [benign DISEASE=Lynch syndrome I,Diarrhea 5, with tufting enteropathy, congenital,Hereditary cancer-predisposing syndrome,Hereditary nonpolyposis colorectal neoplasms,not specified,not provided];			rs1126497	0.6661	0.5769	27689,.	0.8418,0.4720,0.8320,0.4359,0.4807	0.0500	T(1.00),T(1.00)	B(0.00),B(0.00)	11.74	0.18			COSV55392922	0.0873	0.9348	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EPCAM (inh=AR oe_syn=1.27 oe_mis=1.31 oe_lof=0.73), MIR559 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	219552544	219552544	C	T	hom		QUAL=4420;DP=146;AF=1.00;MQM=60;SAP=93;ABP=0	OBSL1	missense	OBSL1:ENST00000373876.5:missense_variant:MODERATE:exon17/20:c.5024G>A:p.Arg1675Gln:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000404537.6:missense_variant:MODERATE:exon18/21:c.5300G>A:p.Arg1767Gln:PF07679 [Immunoglobulin I-set domain]	OBSL1:NM_015311.3:missense_variant:MODERATE:exon18/21:c.5300G>A:p.Arg1767Gln:,OBSL1:XM_011510857.2:missense_variant:MODERATE:exon18/21:c.5300G>A:p.Arg1767Gln:,OBSL1:XM_017003696.2:missense_variant:MODERATE:exon18/21:c.5300G>A:p.Arg1767Gln:,OBSL1:XM_017003697.2:missense_variant:MODERATE:exon18/21:c.5300G>A:p.Arg1767Gln:,OBSL1:XM_017003698.1:missense_variant:MODERATE:exon17/20:c.5024G>A:p.Arg1675Gln:,OBSL1:XM_017003699.1:missense_variant:MODERATE:exon17/20:c.5024G>A:p.Arg1675Gln:,OBSL1:XM_017003700.1:missense_variant:MODERATE:exon16/19:c.4748G>A:p.Arg1583Gln:	regulatory_region_variant:promoter	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	288014 [benign DISEASE=Three M syndrome 2,not specified,not provided];			rs59332477	0.3766	0.4319	14500,.	0.3735,0.5443,0.4201,0.4570,0.2527	1.1840	T(0.81),T(0.33)	D(1.00),D(1.00)	25.60	0.24			COSV54703732	-0.0279	0.4104	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219554514	219554514	T	C	hom		QUAL=14216;DP=466;AF=1.00;MQM=60;SAP=515;ABP=0	OBSL1	synonymous	OBSL1:ENST00000373876.5:synonymous_variant:LOW:exon14/20:c.4560A>G:p.Thr1520=:,OBSL1:ENST00000404537.6:synonymous_variant:LOW:exon15/21:c.4836A>G:p.Thr1612=:	OBSL1:NM_015311.3:synonymous_variant:LOW:exon15/21:c.4836A>G:p.Thr1612=:,OBSL1:XM_011510857.2:synonymous_variant:LOW:exon15/21:c.4836A>G:p.Thr1612=:,OBSL1:XM_011510863.3:intron_variant:MODIFIER:intron14/14:c.4610-1490A>G::,OBSL1:XM_011510865.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*230A>G::,OBSL1:XM_017003696.2:synonymous_variant:LOW:exon15/21:c.4836A>G:p.Thr1612=:,OBSL1:XM_017003697.2:synonymous_variant:LOW:exon15/21:c.4836A>G:p.Thr1612=:,OBSL1:XM_017003698.1:synonymous_variant:LOW:exon14/20:c.4560A>G:p.Thr1520=:,OBSL1:XM_017003699.1:synonymous_variant:LOW:exon14/20:c.4560A>G:p.Thr1520=:,OBSL1:XM_017003700.1:synonymous_variant:LOW:exon13/19:c.4284A>G:p.Thr1428=:		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	334466 [benign DISEASE=Three M syndrome 2,not specified,not provided];			rs10932813		0.9967	74351,.	0.9595,0.9964,1.0000,0.9997,0.9998	-3.9870			2.14					0.0537	0.9246	0.11	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219554617	219554617	T	C	hom		QUAL=21571;DP=692;AF=1.00;MQM=60;SAP=3;ABP=0	OBSL1	missense	OBSL1:ENST00000373876.5:missense_variant:MODERATE:exon14/20:c.4457A>G:p.Gln1486Arg:,OBSL1:ENST00000404537.6:missense_variant:MODERATE:exon15/21:c.4733A>G:p.Gln1578Arg:	OBSL1:NM_015311.3:missense_variant:MODERATE:exon15/21:c.4733A>G:p.Gln1578Arg:,OBSL1:XM_011510857.2:missense_variant:MODERATE:exon15/21:c.4733A>G:p.Gln1578Arg:,OBSL1:XM_011510863.3:intron_variant:MODIFIER:intron14/14:c.4609+1403A>G::,OBSL1:XM_011510865.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*127A>G::,OBSL1:XM_017003696.2:missense_variant:MODERATE:exon15/21:c.4733A>G:p.Gln1578Arg:,OBSL1:XM_017003697.2:missense_variant:MODERATE:exon15/21:c.4733A>G:p.Gln1578Arg:,OBSL1:XM_017003698.1:missense_variant:MODERATE:exon14/20:c.4457A>G:p.Gln1486Arg:,OBSL1:XM_017003699.1:missense_variant:MODERATE:exon14/20:c.4457A>G:p.Gln1486Arg:,OBSL1:XM_017003700.1:missense_variant:MODERATE:exon13/19:c.4181A>G:p.Gln1394Arg:		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	334469 [benign DISEASE=Three M syndrome 2,not specified,not provided];			rs10932814		0.9873	70786,.	0.8802,0.9883,1.0000,0.9941,0.9995	0.1340	T(0.61),T(0.51)	B(0.00),B(0.00)	7.41	0.09				0.0628	0.9247	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219556234	219556234	A	G	hom		QUAL=1388;DP=52;AF=1.00;MQM=60;SAP=91;ABP=0	OBSL1	synonymous	OBSL1:ENST00000373876.5:synonymous_variant:LOW:exon13/20:c.4119T>C:p.Asp1373=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000404537.6:synonymous_variant:LOW:exon14/21:c.4395T>C:p.Asp1465=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926.5:synonymous_variant:LOW:exon14/14:c.4395T>C:p.Asp1465=:PF07679 [Immunoglobulin I-set domain]	OBSL1:NM_001173431.2:synonymous_variant:LOW:exon14/14:c.4395T>C:p.Asp1465=:,OBSL1:NM_015311.3:synonymous_variant:LOW:exon14/21:c.4395T>C:p.Asp1465=:,OBSL1:XM_011510857.2:synonymous_variant:LOW:exon14/21:c.4395T>C:p.Asp1465=:,OBSL1:XM_011510863.3:synonymous_variant:LOW:exon14/15:c.4395T>C:p.Asp1465=:,OBSL1:XM_011510864.2:missense_variant:MODERATE:exon14/14:c.4271T>C:p.Met1424Thr:,OBSL1:XM_011510865.2:missense_variant:MODERATE:exon14/15:c.4271T>C:p.Met1424Thr:,OBSL1:XM_011510866.2:missense_variant:MODERATE:exon13/13:c.3995T>C:p.Met1332Thr:,OBSL1:XM_017003696.2:synonymous_variant:LOW:exon14/21:c.4395T>C:p.Asp1465=:,OBSL1:XM_017003697.2:synonymous_variant:LOW:exon14/21:c.4395T>C:p.Asp1465=:,OBSL1:XM_017003698.1:synonymous_variant:LOW:exon13/20:c.4119T>C:p.Asp1373=:,OBSL1:XM_017003699.1:synonymous_variant:LOW:exon13/20:c.4119T>C:p.Asp1373=:,OBSL1:XM_017003700.1:synonymous_variant:LOW:exon12/19:c.3843T>C:p.Asp1281=:		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	334475 [benign DISEASE=Three M syndrome 2,not specified,not provided];			rs10932816		0.9917	71824,.	0.8885,0.9929,0.9999,0.9996,0.9996	-3.1400			0.29				COSV54708888	0.0395	0.9393	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219556695	219556695	C	G	hom		QUAL=23402;DP=732;AF=1.00;MQM=60;SAP=10;ABP=0	OBSL1	missense	OBSL1:ENST00000373876.5:missense_variant:MODERATE:exon12/20:c.3819G>C:p.Glu1273Asp:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000404537.6:missense_variant:MODERATE:exon13/21:c.4095G>C:p.Glu1365Asp:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926.5:missense_variant:MODERATE:exon13/14:c.4095G>C:p.Glu1365Asp:PF07679 [Immunoglobulin I-set domain]	OBSL1:NM_001173431.2:missense_variant:MODERATE:exon13/14:c.4095G>C:p.Glu1365Asp:,OBSL1:NM_015311.3:missense_variant:MODERATE:exon13/21:c.4095G>C:p.Glu1365Asp:,OBSL1:XM_011510857.2:missense_variant:MODERATE:exon13/21:c.4095G>C:p.Glu1365Asp:,OBSL1:XM_011510863.3:missense_variant:MODERATE:exon13/15:c.4095G>C:p.Glu1365Asp:,OBSL1:XM_011510864.2:missense_variant:MODERATE:exon13/14:c.4095G>C:p.Glu1365Asp:,OBSL1:XM_011510865.2:missense_variant:MODERATE:exon13/15:c.4095G>C:p.Glu1365Asp:,OBSL1:XM_011510866.2:missense_variant:MODERATE:exon12/13:c.3819G>C:p.Glu1273Asp:,OBSL1:XM_017003696.2:missense_variant:MODERATE:exon13/21:c.4095G>C:p.Glu1365Asp:,OBSL1:XM_017003697.2:missense_variant:MODERATE:exon13/21:c.4095G>C:p.Glu1365Asp:,OBSL1:XM_017003698.1:missense_variant:MODERATE:exon12/20:c.3819G>C:p.Glu1273Asp:,OBSL1:XM_017003699.1:missense_variant:MODERATE:exon12/20:c.3819G>C:p.Glu1273Asp:,OBSL1:XM_017003700.1:missense_variant:MODERATE:exon11/19:c.3543G>C:p.Glu1181Asp:		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	334483 [benign DISEASE=Three M syndrome 2,not specified,not provided];			rs1983210		0.7384	37847,.	0.6130,0.6707,0.7101,0.7404,0.8941	0.6310	T(0.27),T(0.23),T(0.13)	P(0.77),P(0.76),D(0.95)	22.50	0.17			COSV54706342	-0.0856	0.6619	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219567987	219567987	A	T	het	off-target	QUAL=9163;DP=724;AF=0.48;MQM=60;SAP=3;ABP=5	OBSL1	intron	OBSL1:ENST00000289656.3:intron_variant:MODIFIER:intron2/8:c.44-18T>A::,OBSL1:ENST00000373873.8:intron_variant:MODIFIER:intron2/8:c.1283-18T>A::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron2/19:c.1283-18T>A::,OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron2/20:c.1283-18T>A::,OBSL1:ENST00000603926.5:intron_variant:MODIFIER:intron2/13:c.1283-18T>A::	OBSL1:NM_001173408.2:intron_variant:MODIFIER:intron2/8:c.1283-18T>A::,OBSL1:NM_001173431.2:intron_variant:MODIFIER:intron2/13:c.1283-18T>A::,OBSL1:NM_015311.3:intron_variant:MODIFIER:intron2/20:c.1283-18T>A::,OBSL1:XM_011510857.2:intron_variant:MODIFIER:intron2/20:c.1283-18T>A::,OBSL1:XM_011510863.3:intron_variant:MODIFIER:intron2/14:c.1283-18T>A::,OBSL1:XM_011510864.2:intron_variant:MODIFIER:intron2/13:c.1283-18T>A::,OBSL1:XM_011510865.2:intron_variant:MODIFIER:intron2/14:c.1283-18T>A::,OBSL1:XM_011510866.2:intron_variant:MODIFIER:intron2/12:c.1283-18T>A::,OBSL1:XM_017003696.2:intron_variant:MODIFIER:intron2/20:c.1283-18T>A::,OBSL1:XM_017003697.2:intron_variant:MODIFIER:intron2/20:c.1283-18T>A::,OBSL1:XM_017003698.1:intron_variant:MODIFIER:intron2/19:c.1283-18T>A::,OBSL1:XM_017003699.1:intron_variant:MODIFIER:intron2/19:c.1283-18T>A::,OBSL1:XM_017003700.1:intron_variant:MODIFIER:intron2/18:c.1283-18T>A::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1174895 [benign DISEASE=not specified];			rs2292360	0.3678	0.4229	11489,.	0.1795,0.3641,0.4921,0.4523,0.4414	-1.0910			2.08		6.52>5.43		COSV54726835	-0.4298	0.872	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70), INHA (inh=n/a oe_syn=1.26 oe_mis=0.91 oe_lof=0.48)
chr2	219570312	219570312	A	G	hom		QUAL=20371;DP=649;AF=1.00;MQM=60;SAP=3;ABP=0	OBSL1	intron,synonymous	OBSL1:ENST00000289656.3:intron_variant:MODIFIER:intron1/8:c.-228+1082T>C::,OBSL1:ENST00000373873.8:synonymous_variant:LOW:exon1/9:c.921T>C:p.Leu307=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373876.5:synonymous_variant:LOW:exon1/20:c.921T>C:p.Leu307=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000404537.6:synonymous_variant:LOW:exon1/21:c.921T>C:p.Leu307=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926.5:synonymous_variant:LOW:exon1/14:c.921T>C:p.Leu307=:PF07679 [Immunoglobulin I-set domain]	OBSL1:NM_001173408.2:synonymous_variant:LOW:exon1/9:c.921T>C:p.Leu307=:,OBSL1:NM_001173431.2:synonymous_variant:LOW:exon1/14:c.921T>C:p.Leu307=:,OBSL1:NM_015311.3:synonymous_variant:LOW:exon1/21:c.921T>C:p.Leu307=:,OBSL1:XM_011510857.2:synonymous_variant:LOW:exon1/21:c.921T>C:p.Leu307=:,OBSL1:XM_011510863.3:synonymous_variant:LOW:exon1/15:c.921T>C:p.Leu307=:,OBSL1:XM_011510864.2:synonymous_variant:LOW:exon1/14:c.921T>C:p.Leu307=:,OBSL1:XM_011510865.2:synonymous_variant:LOW:exon1/15:c.921T>C:p.Leu307=:,OBSL1:XM_011510866.2:synonymous_variant:LOW:exon1/13:c.921T>C:p.Leu307=:,OBSL1:XM_017003696.2:synonymous_variant:LOW:exon1/21:c.921T>C:p.Leu307=:,OBSL1:XM_017003697.2:synonymous_variant:LOW:exon1/21:c.921T>C:p.Leu307=:,OBSL1:XM_017003698.1:synonymous_variant:LOW:exon1/20:c.921T>C:p.Leu307=:,OBSL1:XM_017003699.1:synonymous_variant:LOW:exon1/20:c.921T>C:p.Leu307=:,OBSL1:XM_017003700.1:synonymous_variant:LOW:exon1/19:c.921T>C:p.Leu307=:	regulatory_region_variant:promoter	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	193382 [benign DISEASE=Three M syndrome 2,not specified,not provided];			rs10180675		0.8651	51711,.	0.6051,0.8299,0.9153,0.9035,0.8331	-0.3330			13.57				COSV54725784	0.0231	0.8817	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70), INHA (inh=n/a oe_syn=1.26 oe_mis=0.91 oe_lof=0.48)
chr2	219570653	219570653	G	A	het		QUAL=384;DP=19;AF=0.84;MQM=60;SAP=4;ABP=22	OBSL1	intron,synonymous	OBSL1:ENST00000289656.3:intron_variant:MODIFIER:intron1/8:c.-228+741C>T::,OBSL1:ENST00000373873.8:synonymous_variant:LOW:exon1/9:c.580C>T:p.Leu194=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373876.5:synonymous_variant:LOW:exon1/20:c.580C>T:p.Leu194=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000404537.6:synonymous_variant:LOW:exon1/21:c.580C>T:p.Leu194=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926.5:synonymous_variant:LOW:exon1/14:c.580C>T:p.Leu194=:PF07679 [Immunoglobulin I-set domain]	OBSL1:NM_001173408.2:synonymous_variant:LOW:exon1/9:c.580C>T:p.Leu194=:,OBSL1:NM_001173431.2:synonymous_variant:LOW:exon1/14:c.580C>T:p.Leu194=:,OBSL1:NM_015311.3:synonymous_variant:LOW:exon1/21:c.580C>T:p.Leu194=:,OBSL1:XM_011510857.2:synonymous_variant:LOW:exon1/21:c.580C>T:p.Leu194=:,OBSL1:XM_011510863.3:synonymous_variant:LOW:exon1/15:c.580C>T:p.Leu194=:,OBSL1:XM_011510864.2:synonymous_variant:LOW:exon1/14:c.580C>T:p.Leu194=:,OBSL1:XM_011510865.2:synonymous_variant:LOW:exon1/15:c.580C>T:p.Leu194=:,OBSL1:XM_011510866.2:synonymous_variant:LOW:exon1/13:c.580C>T:p.Leu194=:,OBSL1:XM_017003696.2:synonymous_variant:LOW:exon1/21:c.580C>T:p.Leu194=:,OBSL1:XM_017003697.2:synonymous_variant:LOW:exon1/21:c.580C>T:p.Leu194=:,OBSL1:XM_017003698.1:synonymous_variant:LOW:exon1/20:c.580C>T:p.Leu194=:,OBSL1:XM_017003699.1:synonymous_variant:LOW:exon1/20:c.580C>T:p.Leu194=:,OBSL1:XM_017003700.1:synonymous_variant:LOW:exon1/19:c.580C>T:p.Leu194=:	regulatory_region_variant:promoter	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	290129 [benign DISEASE=Three M syndrome 2,not specified,not provided];			rs1061399	0.3588	0.4289	11133,.	0.1596,0.3684,0.4918,0.4562,0.4435	3.2570			13.56				COSV54727864	0.0447	0.9102	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70), INHA (inh=n/a oe_syn=1.26 oe_mis=0.91 oe_lof=0.48)
chr3	10035159	10035160	TT	-	het	off-target	QUAL=1941;DP=168;AF=0.45;MQM=60;SAP=10;ABP=7	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron5/42:c.378-6_378-5del::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron5/43:c.378-6_378-5del::,FANCD2:ENST00000431693.1:intron_variant:MODIFIER:intron4/7:c.378-6_378-5del::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron5/43:c.378-6_378-5del::	FANCD2:NM_001018115.3:intron_variant:MODIFIER:intron5/43:c.378-6_378-5del::,FANCD2:NM_001319984.2:intron_variant:MODIFIER:intron5/43:c.378-6_378-5del::,FANCD2:NM_001374253.1:intron_variant:MODIFIER:intron5/42:c.378-6_378-5del::,FANCD2:NM_001374254.1:intron_variant:MODIFIER:intron5/41:c.378-6_378-5del::,FANCD2:NM_001374255.1:intron_variant:MODIFIER:intron5/9:c.378-6_378-5del::,FANCD2:NM_033084.6:intron_variant:MODIFIER:intron5/42:c.378-6_378-5del::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	342255 [benign/likely benign DISEASE=Fanconi anemia, complementation group D2,Fanconi anemia,not provided];			rs55973240		0.2327	4993,.	0.4744,0.2346,0.0966,0.2132,0.2534	0.3340			4.32					-0.6462	0.5413	0.11	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10035291	10035291	A	C	het	off-target	QUAL=1279;DP=99;AF=0.48;MQM=60;SAP=12;ABP=3	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron6/42:c.438+58A>C::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron6/43:c.438+58A>C::,FANCD2:ENST00000431693.1:intron_variant:MODIFIER:intron5/7:c.438+58A>C::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron6/43:c.438+58A>C::	FANCD2:NM_001018115.3:intron_variant:MODIFIER:intron6/43:c.438+58A>C::,FANCD2:NM_001319984.2:intron_variant:MODIFIER:intron6/43:c.438+58A>C::,FANCD2:NM_001374253.1:intron_variant:MODIFIER:intron6/42:c.438+58A>C::,FANCD2:NM_001374254.1:intron_variant:MODIFIER:intron6/41:c.438+58A>C::,FANCD2:NM_001374255.1:intron_variant:MODIFIER:intron6/9:c.438+58A>C::,FANCD2:NM_033084.6:intron_variant:MODIFIER:intron6/42:c.438+58A>C::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1271812 [benign DISEASE=not provided];			rs17032276	0.1811	0.1969	3454,.		2.2790			14.26					-0.022	0.1335	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10036271	10036271	A	G	het	off-target	QUAL=553;DP=46;AF=0.63;MQM=60;SAP=66;ABP=10	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron6/42:c.439-16A>G::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron6/43:c.439-16A>G::,FANCD2:ENST00000431693.1:intron_variant:MODIFIER:intron5/7:c.439-16A>G::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron6/43:c.439-16A>G::	FANCD2:NM_001018115.3:intron_variant:MODIFIER:intron6/43:c.439-16A>G::,FANCD2:NM_001319984.2:intron_variant:MODIFIER:intron6/43:c.439-16A>G::,FANCD2:NM_001374253.1:intron_variant:MODIFIER:intron6/42:c.439-16A>G::,FANCD2:NM_001374254.1:intron_variant:MODIFIER:intron6/41:c.439-16A>G::,FANCD2:NM_001374255.1:intron_variant:MODIFIER:intron6/9:c.439-16A>G::,FANCD2:NM_033084.6:intron_variant:MODIFIER:intron6/42:c.439-16A>G::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257083 [benign DISEASE=Fanconi anemia, complementation group D2,not specified,not provided];			rs17032278	0.1821	0.1965	3419,.	0.3358,0.1545,0.0657,0.1590,0.1770	-0.7230			0.15		10.11>10.91			0.4466	0.0179	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10039861	10039861	G	C	het	off-target	QUAL=5185;DP=484;AF=0.47;MQM=60;SAP=3;ABP=6	FANCD2	intron,synonymous	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron9/42:c.695+16G>C::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron9/43:c.695+16G>C::,FANCD2:ENST00000431693.1:synonymous_variant:LOW:exon8/8:c.711G>C:p.Leu237=:,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron9/43:c.695+16G>C::	FANCD2:NM_001018115.3:intron_variant:MODIFIER:intron9/43:c.695+16G>C::,FANCD2:NM_001319984.2:intron_variant:MODIFIER:intron9/43:c.695+16G>C::,FANCD2:NM_001374253.1:intron_variant:MODIFIER:intron9/42:c.695+16G>C::,FANCD2:NM_001374254.1:intron_variant:MODIFIER:intron9/41:c.695+16G>C::,FANCD2:NM_001374255.1:intron_variant:MODIFIER:intron9/9:c.695+16G>C::,FANCD2:NM_033084.6:intron_variant:MODIFIER:intron9/42:c.695+16G>C::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257086 [benign DISEASE=Fanconi anemia, complementation group D2,not specified,not provided];			rs17032283	0.1821	0.1971	3453,.	0.3332,0.1546,0.0657,0.1586,0.1767	-0.1270			2.65				COSV55047412	0.1779	0.948	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10042540	10042540	C	T	het	off-target	QUAL=14508;DP=1027;AF=0.54;MQM=60;SAP=3;ABP=14	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron10/42:c.784-19C>T::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron10/43:c.784-19C>T::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron10/43:c.784-19C>T::	FANCD2:NM_001018115.3:intron_variant:MODIFIER:intron10/43:c.784-19C>T::,FANCD2:NM_001319984.2:intron_variant:MODIFIER:intron10/43:c.784-19C>T::,FANCD2:NM_001374253.1:intron_variant:MODIFIER:intron10/42:c.784-19C>T::,FANCD2:NM_001374254.1:intron_variant:MODIFIER:intron10/41:c.784-19C>T::,FANCD2:NM_033084.6:intron_variant:MODIFIER:intron10/42:c.784-19C>T::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257087 [benign DISEASE=Fanconi anemia, complementation group D2,not specified,not provided];			rs9879080	0.2107	0.2257	5005,.	0.4323,0.1579,0.0654,0.1593,0.1753	0.8720			7.43		12.10>11.70		COSV55047416	0.3101	0.058	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10043446	10043446	C	G	het	off-target	QUAL=62;DP=10;AF=0.40;MQM=60;SAP=12;ABP=4	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron12/42:c.990-38C>G::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron12/43:c.990-38C>G::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron12/43:c.990-38C>G::	FANCD2:NM_001018115.3:intron_variant:MODIFIER:intron12/43:c.990-38C>G::,FANCD2:NM_001319984.2:intron_variant:MODIFIER:intron12/43:c.990-38C>G::,FANCD2:NM_001374253.1:intron_variant:MODIFIER:intron12/42:c.990-38C>G::,FANCD2:NM_001374254.1:intron_variant:MODIFIER:intron12/41:c.990-38C>G::,FANCD2:NM_033084.6:intron_variant:MODIFIER:intron12/42:c.990-38C>G::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257088 [benign DISEASE=Fanconi anemia, complementation group D2,not specified,not provided];			rs9809061	0.2117	0.2261	5019,.	0.4320,0.1572,0.0653,0.1583,0.1770	-0.9250			4.88					-0.2598	0.2771	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10043852	10043852	A	G	het		QUAL=2144;DP=294;AF=0.43;MQM=60;SAP=182;ABP=16	FANCD2	synonymous	FANCD2:ENST00000287647.7:synonymous_variant:LOW:exon14/43:c.1122A>G:p.Val374=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000419585.5:synonymous_variant:LOW:exon14/44:c.1122A>G:p.Val374=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000675286.1:synonymous_variant:LOW:exon14/44:c.1122A>G:p.Val374=:PF14631 [Fanconi anaemia protein FancD2 nuclease]	FANCD2:NM_001018115.3:synonymous_variant:LOW:exon14/44:c.1122A>G:p.Val374=:,FANCD2:NM_001319984.2:synonymous_variant:LOW:exon14/44:c.1122A>G:p.Val374=:,FANCD2:NM_001374253.1:synonymous_variant:LOW:exon14/43:c.1122A>G:p.Val374=:,FANCD2:NM_001374254.1:synonymous_variant:LOW:exon14/42:c.1122A>G:p.Val374=:,FANCD2:NM_033084.6:synonymous_variant:LOW:exon14/43:c.1122A>G:p.Val374=:		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257065 [benign DISEASE=Fanconi anemia, complementation group D2,Fanconi anemia, complementation group A,Fanconi anemia,not specified,not provided];			rs34046352		0.1929	235,.	0.2875,0.0988,0.0387,0.0796,0.0881	-0.0460			1.33				COSV55037937	-0.0486	0.1597	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10048039	10048039	G	A	het		QUAL=89;DP=144;AF=0.20;MQM=40;SAP=9;ABP=115	FANCD2	synonymous	FANCD2:ENST00000287647.7:synonymous_variant:LOW:exon16/43:c.1401G>A:p.Thr467=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000419585.5:synonymous_variant:LOW:exon16/44:c.1401G>A:p.Thr467=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000675286.1:synonymous_variant:LOW:exon16/44:c.1401G>A:p.Thr467=:PF14631 [Fanconi anaemia protein FancD2 nuclease]	FANCD2:NM_001018115.3:synonymous_variant:LOW:exon16/44:c.1401G>A:p.Thr467=:,FANCD2:NM_001319984.2:synonymous_variant:LOW:exon16/44:c.1401G>A:p.Thr467=:,FANCD2:NM_001374253.1:synonymous_variant:LOW:exon16/43:c.1401G>A:p.Thr467=:,FANCD2:NM_001374254.1:synonymous_variant:LOW:exon16/42:c.1401G>A:p.Thr467=:,FANCD2:NM_033084.6:synonymous_variant:LOW:exon16/43:c.1401G>A:p.Thr467=:		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	342267 [benign/likely benign DISEASE=Fanconi anemia, complementation group D2,not specified,not provided];			rs12330369		0.4610	0,.	0.4704,0.3503,0.3800,0.4470,0.3738	0.0140			4.83				COSV55032260	-0.1003	0.9383	0.1	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	142449489	142449489	C	T	hom		QUAL=1594;DP=49;AF=1.00;MQM=60;SAP=4;ABP=0	ATR	synonymous	ATR:ENST00000350721.9:synonymous_variant:LOW:exon47/47:c.7875G>A:p.Gln2625=:PF02260 [FATC domain],ATR:ENST00000661310.1:synonymous_variant:LOW:exon46/46:c.7683G>A:p.Gln2561=:PF02260 [FATC domain]	ATR:NM_001184.4:synonymous_variant:LOW:exon47/47:c.7875G>A:p.Gln2625=:,ATR:NM_001354579.2:synonymous_variant:LOW:exon46/46:c.7683G>A:p.Gln2561=:,ATR:XM_011512924.1:synonymous_variant:LOW:exon47/47:c.7881G>A:p.Gln2627=:,ATR:XM_011512925.1:synonymous_variant:LOW:exon46/46:c.7689G>A:p.Gln2563=:,ATR:XR_001740179.2:non_coding_transcript_exon_variant:MODIFIER:exon48/48:n.8101G>A::,ATR:XR_924148.2:non_coding_transcript_exon_variant:MODIFIER:exon48/48:n.8107G>A::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	93669 [benign/likely benign DISEASE=Seckel syndrome 1,not specified,not provided];			rs1802904		0.8866	60074,.	0.9733,0.7565,0.9333,0.8561,0.9373	1.2390			6.93				COSV99377126	0.0243	0.9305	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					XRN1 (inh=n/a oe_syn=0.94 oe_mis=0.80 oe_lof=0.12), ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142459302	142459302	C	T	het		QUAL=1052;DP=77;AF=0.55;MQM=60;SAP=8;ABP=4	ATR	missense	ATR:ENST00000350721.9:missense_variant:MODERATE:exon43/47:c.7274G>A:p.Arg2425Gln:PF00454 [Phosphatidylinositol 3- and 4-kinase],ATR:ENST00000661310.1:missense_variant:MODERATE:exon42/46:c.7082G>A:p.Arg2361Gln:PF00454 [Phosphatidylinositol 3- and 4-kinase]	ATR:NM_001184.4:missense_variant:MODERATE:exon43/47:c.7274G>A:p.Arg2425Gln:,ATR:NM_001354579.2:missense_variant:MODERATE:exon42/46:c.7082G>A:p.Arg2361Gln:,ATR:XM_011512924.1:missense_variant:MODERATE:exon43/47:c.7280G>A:p.Arg2427Gln:,ATR:XM_011512925.1:missense_variant:MODERATE:exon42/46:c.7088G>A:p.Arg2363Gln:,ATR:XR_001740179.2:non_coding_transcript_exon_variant:MODIFIER:exon43/48:n.7363G>A::,ATR:XR_924148.2:non_coding_transcript_exon_variant:MODIFIER:exon43/48:n.7369G>A::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	136470 [benign DISEASE=Seckel syndrome 1,not specified,not provided];	CM1010619 [CLASS=DP MUT=ALT PHEN="Acute rejection in kidney transplantation association with" GENE=ATR];		rs2229032	0.1022	0.1306	1340,.	0.0795,0.0994,0.0982,0.1599,0.0957	0.0370	T(0.23),T(0.23)	B(0.00),B(0.00)	0.70	0.17			COSV63383988	-0.029	0.1133	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142469495	142469495	A	C	het		QUAL=9936;DP=681;AF=0.56;MQM=60;SAP=4;ABP=26	ATR,	missense,intron&non_coding_transcript	ATR:ENST00000350721.9:missense_variant:MODERATE:exon38/47:c.6394T>G:p.Tyr2132Asp:,:ENST00000460977.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.268+2575T>G::,ATR:ENST00000661310.1:missense_variant:MODERATE:exon37/46:c.6202T>G:p.Tyr2068Asp:	ATR:NM_001184.4:missense_variant:MODERATE:exon38/47:c.6394T>G:p.Tyr2132Asp:,ATR:NM_001354579.2:missense_variant:MODERATE:exon37/46:c.6202T>G:p.Tyr2068Asp:,ATR:XM_011512924.1:missense_variant:MODERATE:exon38/47:c.6400T>G:p.Tyr2134Asp:,ATR:XM_011512925.1:missense_variant:MODERATE:exon37/46:c.6208T>G:p.Tyr2070Asp:,ATR:XR_001740179.2:non_coding_transcript_exon_variant:MODIFIER:exon38/48:n.6483T>G::,ATR:XR_924148.2:non_coding_transcript_exon_variant:MODIFIER:exon38/48:n.6489T>G::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	158000 [benign/likely benign DISEASE=Seckel syndrome 1,not specified,not provided];	CM1725174 [CLASS=DP MUT=ALT PHEN="Haematological traits association with" GENE=ATR];		rs28910273	0.0020	0.0034	0,.	0.0016,0.0016,0.0000,0.0056,0.0014	2.4040	T(0.06), ,T(0.07)	B(0.01), ,B(0.01)	20.90	0.05			COSV63384218	0.1884	0.1512	0.03	0	133	0 / 13	2	"[2] Ilnaz Sepahi 29-03-2016 batch import"			ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142496329	142496329	T	C	het	off-target	QUAL=124;DP=8;AF=0.75;MQM=60;SAP=16;ABP=7	ATR	intron	ATR:ENST00000350721.9:intron_variant:MODIFIER:intron34/46:c.5898+32A>G::,ATR:ENST00000661310.1:intron_variant:MODIFIER:intron33/45:c.5706+32A>G::	ATR:NM_001184.4:intron_variant:MODIFIER:intron34/46:c.5898+32A>G::,ATR:NM_001354579.2:intron_variant:MODIFIER:intron33/45:c.5706+32A>G::,ATR:XM_011512924.1:intron_variant:MODIFIER:intron34/46:c.5904+32A>G::,ATR:XM_011512925.1:intron_variant:MODIFIER:intron33/45:c.5712+32A>G::,ATR:XR_001740179.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron34/47:n.5987+32A>G::,ATR:XR_001740180.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron34/37:n.5993+32A>G::,ATR:XR_001740181.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron34/37:n.5872+32A>G::,ATR:XR_001740182.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron34/37:n.5872+32A>G::,ATR:XR_002959543.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron34/38:n.5993+32A>G::,ATR:XR_924148.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron34/47:n.5993+32A>G::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	157998 [likely benign DISEASE=not specified];		(TA)n (Simple_repeat)	rs11719960		0.0439	406,.	0.0000,0.0001,0.0003,0.0002,0.0002	-1.5210			0.12				COSV63384221	-0.0109	0.156	0.01	240	2486	32 / 282					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr17	35118530	35118530	G	A	het		QUAL=1656;DP=131;AF=0.55;MQM=60;SAP=7;ABP=6	RAD51D,	intron,synonymous	RAD51D:ENST00000335858.11:intron_variant:MODIFIER:intron2/6:c.144+581C>T::,RAD51D:ENST00000345365.11:synonymous_variant:LOW:exon3/10:c.234C>T:p.Ser78=:PF08423 [Rad51],RAD51D:ENST00000394589.8:synonymous_variant:LOW:exon4/11:c.234C>T:p.Ser78=:PF08423 [Rad51],RAD51D:ENST00000460118.6:intron_variant:MODIFIER:intron2/8:c.-208+581C>T::,RAD51D:ENST00000590016.5:intron_variant:MODIFIER:intron2/9:c.144+581C>T::,:ENST00000593039.5:intron_variant:MODIFIER:intron1/6:c.3+2761C>T::	RAD51D:NM_001142571.2:intron_variant:MODIFIER:intron2/9:c.144+581C>T::,RAD51D:NM_002878.4:synonymous_variant:LOW:exon3/10:c.234C>T:p.Ser78=:,RAD51D:NM_133629.3:intron_variant:MODIFIER:intron2/6:c.144+581C>T::,RAD51D:NR_037711.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/8:n.289+581C>T::,RAD51D:NR_037712.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/7:n.289+581C>T::,RAD51L3-RFFL:NR_037714.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.232+2761C>T::	regulatory_region_variant:CTCF_binding_site	602954_[GENE=RAD51D_PHENOS={Breast-ovarian cancer, familial, susceptibility to, 4}, 614291 (3)]	183785 [benign DISEASE=Breast-ovarian cancer, familial 4,Hereditary cancer-predisposing syndrome,not specified,not provided];			rs9901455	0.1875	0.1558	2577,.	0.3055,0.1043,0.2299,0.0821,0.0860	1.6750			17.75				COSV99338663	-0.0467	0.6691	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51D (inh=n/a oe_syn=1.01 oe_mis=1.02 oe_lof=0.80), FNDC8 (inh=n/a oe_syn=0.99 oe_mis=0.91 oe_lof=0.69)
chr17	43071077	43071077	T	C	het		QUAL=4362;DP=432;AF=0.47;MQM=60;SAP=269;ABP=6	BRCA1	missense,intron	BRCA1:ENST00000352993.7:missense_variant:MODERATE:exon14/22:c.1411A>G:p.Ser471Gly:,BRCA1:ENST00000357654.9:missense_variant:MODERATE:exon15/23:c.4837A>G:p.Ser1613Gly:,BRCA1:ENST00000468300.5:missense_variant:MODERATE:exon15/22:c.1525A>G:p.Ser509Gly:,BRCA1:ENST00000471181.7:missense_variant:MODERATE:exon16/24:c.4900A>G:p.Ser1634Gly:,BRCA1:ENST00000491747.6:missense_variant:MODERATE:exon15/23:c.1525A>G:p.Ser509Gly:,BRCA1:ENST00000493795.5:missense_variant:MODERATE:exon14/22:c.4696A>G:p.Ser1566Gly:,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-7126A>G::,BRCA1:ENST00000591534.5:missense_variant:MODERATE:exon3/11:c.310A>G:p.Ser104Gly:,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-98-20887A>G::	BRCA1:NM_007294.4:missense_variant:MODERATE:exon15/23:c.4837A>G:p.Ser1613Gly:,BRCA1:NM_007297.4:missense_variant:MODERATE:exon14/22:c.4696A>G:p.Ser1566Gly:,BRCA1:NM_007298.3:missense_variant:MODERATE:exon14/22:c.1525A>G:p.Ser509Gly:,BRCA1:NM_007299.4:missense_variant:MODERATE:exon15/22:c.1525A>G:p.Ser509Gly:,BRCA1:NM_007300.4:missense_variant:MODERATE:exon16/24:c.4900A>G:p.Ser1634Gly:,BRCA1:NR_027676.2:non_coding_transcript_exon_variant:MODIFIER:exon15/23:n.5014A>G::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Autosomal dominant, Multifactorial; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	41827 [benign DISEASE=Breast carcinoma,Hereditary breast and ovarian cancer syndrome,Malignant tumor of breast,Breast-ovarian cancer, familial 1,Breast-ovarian cancer, familial 2,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,none provided,not provided];	CM1210129 [CLASS=R MUT=ALT PHEN="Breast cancer" GENE=BRCA1];		rs1799966	0.3558	0.3539	8001,.	0.2404,0.3171,0.3801,0.3259,0.5041	-0.1940	T(0.11),T(0.11),T(0.12),T(0.12),T(0.10),T(0.11), ,T(0.20), 	B(0.01),B(0.04),B(0.00),B(0.07),B(0.02),B(0.04), ,B(0.04), 	8.64	0.25			COSV58783381	-0.0744	0.319	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43082453	43082453	A	G	het		QUAL=343;DP=34;AF=0.50;MQM=60;SAP=25;ABP=3	BRCA1	synonymous,intron	BRCA1:ENST00000352993.7:synonymous_variant:LOW:exon11/22:c.882T>C:p.Ser294=:,BRCA1:ENST00000357654.9:synonymous_variant:LOW:exon12/23:c.4308T>C:p.Ser1436=:,BRCA1:ENST00000468300.5:synonymous_variant:LOW:exon12/22:c.999T>C:p.Ser333=:,BRCA1:ENST00000471181.7:synonymous_variant:LOW:exon12/24:c.4308T>C:p.Ser1436=:,BRCA1:ENST00000491747.6:synonymous_variant:LOW:exon12/23:c.999T>C:p.Ser333=:,BRCA1:ENST00000493795.5:synonymous_variant:LOW:exon11/22:c.4167T>C:p.Ser1389=:,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-18502T>C::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-7932T>C::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-98-32263T>C::	BRCA1:NM_007294.4:synonymous_variant:LOW:exon12/23:c.4308T>C:p.Ser1436=:,BRCA1:NM_007297.4:synonymous_variant:LOW:exon11/22:c.4167T>C:p.Ser1389=:,BRCA1:NM_007298.3:synonymous_variant:LOW:exon11/22:c.999T>C:p.Ser333=:,BRCA1:NM_007299.4:synonymous_variant:LOW:exon12/22:c.999T>C:p.Ser333=:,BRCA1:NM_007300.4:synonymous_variant:LOW:exon12/24:c.4308T>C:p.Ser1436=:,BRCA1:NR_027676.2:non_coding_transcript_exon_variant:MODIFIER:exon12/23:n.4485T>C::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Autosomal dominant, Multifactorial; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	125703 [benign DISEASE=Hereditary breast and ovarian cancer syndrome,Breast-ovarian cancer, familial 1,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,none provided,not provided];	CM1719086 [CLASS=R MUT=ALT PHEN="Breast cancer" GENE=BRCA1];		rs1060915	0.3363	0.3485	7437,.	0.1820,0.3116,0.3787,0.3255,0.5038	0.1030			3.88				COSV58783806	-0.001	0.3454	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73), RPL21P4 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr17	43091983	43091983	T	C	het		QUAL=4694;DP=350;AF=0.49;MQM=60;SAP=4;ABP=3	BRCA1	intron,missense	BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron9/21:c.671-951A>G::,BRCA1:ENST00000354071.7:missense_variant:MODERATE:exon10/10:c.3548A>G:p.Lys1183Arg:,BRCA1:ENST00000357654.9:missense_variant:MODERATE:exon10/23:c.3548A>G:p.Lys1183Arg:,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron10/21:c.788-951A>G::,BRCA1:ENST00000471181.7:missense_variant:MODERATE:exon10/24:c.3548A>G:p.Lys1183Arg:,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron10/22:c.788-951A>G::,BRCA1:ENST00000493795.5:missense_variant:MODERATE:exon9/22:c.3407A>G:p.Lys1136Arg:,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-28032A>G::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-17462A>G::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+33288A>G::	BRCA1:NM_007294.4:missense_variant:MODERATE:exon10/23:c.3548A>G:p.Lys1183Arg:,BRCA1:NM_007297.4:missense_variant:MODERATE:exon9/22:c.3407A>G:p.Lys1136Arg:,BRCA1:NM_007298.3:intron_variant:MODIFIER:intron9/21:c.788-951A>G::,BRCA1:NM_007299.4:intron_variant:MODIFIER:intron10/21:c.788-951A>G::,BRCA1:NM_007300.4:missense_variant:MODERATE:exon10/24:c.3548A>G:p.Lys1183Arg:,BRCA1:NR_027676.2:non_coding_transcript_exon_variant:MODIFIER:exon10/23:n.3725A>G::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Autosomal dominant, Multifactorial; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	41818 [benign DISEASE=Breast carcinoma,Hereditary breast and ovarian cancer syndrome,Breast-ovarian cancer, familial 1,Breast-ovarian cancer, familial 2,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,none provided,not provided];	CM058359 [CLASS=DP MUT=ALT PHEN="Breast cancer protection against association with" GENE=BRCA1];		rs16942	0.3526	0.3527	7887,.	0.2365,0.3164,0.3795,0.3242,0.5039	-0.3190	 ,T(1.00),T(1.00), ,T(1.00), ,T(1.00), , , 	 ,B(0.00),B(0.00), ,B(0.00), ,B(0.00), , , 	1.10	0.07			COSV58784397	0.0032	0.8933	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43092418	43092418	T	C	het		QUAL=10833;DP=980;AF=0.49;MQM=60;SAP=4;ABP=5	BRCA1	intron,missense	BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron9/21:c.671-1386A>G::,BRCA1:ENST00000354071.7:missense_variant:MODERATE:exon10/10:c.3113A>G:p.Glu1038Gly:,BRCA1:ENST00000357654.9:missense_variant:MODERATE:exon10/23:c.3113A>G:p.Glu1038Gly:,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron10/21:c.788-1386A>G::,BRCA1:ENST00000471181.7:missense_variant:MODERATE:exon10/24:c.3113A>G:p.Glu1038Gly:,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron10/22:c.788-1386A>G::,BRCA1:ENST00000493795.5:missense_variant:MODERATE:exon9/22:c.2972A>G:p.Glu991Gly:,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-28467A>G::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-17897A>G::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+32853A>G::	BRCA1:NM_007294.4:missense_variant:MODERATE:exon10/23:c.3113A>G:p.Glu1038Gly:,BRCA1:NM_007297.4:missense_variant:MODERATE:exon9/22:c.2972A>G:p.Glu991Gly:,BRCA1:NM_007298.3:intron_variant:MODIFIER:intron9/21:c.788-1386A>G::,BRCA1:NM_007299.4:intron_variant:MODIFIER:intron10/21:c.788-1386A>G::,BRCA1:NM_007300.4:missense_variant:MODERATE:exon10/24:c.3113A>G:p.Glu1038Gly:,BRCA1:NR_027676.2:non_coding_transcript_exon_variant:MODIFIER:exon10/23:n.3290A>G::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Autosomal dominant, Multifactorial; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	41815 [benign DISEASE=Breast carcinoma,Hereditary breast and ovarian cancer syndrome,Malignant tumor of breast,Breast-ovarian cancer, familial 1,Breast-ovarian cancer, familial 2,Pancreatic cancer 4,Hereditary cancer-predisposing syndrome,Familial cancer of breast,Fanconi anemia, complementation group S,not specified,none provided,not provided];	CM032861 [CLASS=DP MUT=ALT PHEN="Endometriosis association with" GENE=BRCA1];		rs16941	0.3357	0.3483	7401,.	0.1818,0.3112,0.3789,0.3252,0.5035	-0.1490	 ,T(0.06),T(0.16), ,T(0.17), ,T(0.15), , , 	 ,B(0.12),P(0.61), ,B(0.00), ,P(0.61), , , 	14.07	0.23			COSV58786412	0.0013	0.8933	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr18	22984838	22984840	TCA	-	het	off-target	QUAL=362;DP=32;AF=0.47;MQM=60;SAP=3;ABP=3	RBBP8	intron	RBBP8:ENST00000327155.10:intron_variant:MODIFIER:intron7/18:c.605-41_605-39del::,RBBP8:ENST00000360790.9:intron_variant:MODIFIER:intron7/18:c.605-41_605-39del::,RBBP8:ENST00000399722.6:intron_variant:MODIFIER:intron7/18:c.605-41_605-39del::,RBBP8:ENST00000399725.6:intron_variant:MODIFIER:intron7/17:c.605-41_605-39del::	RBBP8:NM_002894.3:intron_variant:MODIFIER:intron7/18:c.605-41_605-39del::,RBBP8:NM_203291.2:intron_variant:MODIFIER:intron7/18:c.605-41_605-39del::,RBBP8:NM_203292.2:intron_variant:MODIFIER:intron7/17:c.605-41_605-39del::,RBBP8:XM_005258325.3:intron_variant:MODIFIER:intron7/17:c.605-41_605-39del::,RBBP8:XM_005258326.4:intron_variant:MODIFIER:intron6/17:c.-312-41_-312-39del::,RBBP8:XM_006722519.2:intron_variant:MODIFIER:intron9/20:c.605-41_605-39del::,RBBP8:XM_006722520.2:intron_variant:MODIFIER:intron8/19:c.605-41_605-39del::,RBBP8:XM_006722521.2:intron_variant:MODIFIER:intron7/18:c.605-41_605-39del::,RBBP8:XM_011526132.2:intron_variant:MODIFIER:intron8/19:c.605-41_605-39del::,RBBP8:XM_017025916.1:intron_variant:MODIFIER:intron8/18:c.-312-41_-312-39del::,RBBP8:XM_024451233.1:intron_variant:MODIFIER:intron8/19:c.311-41_311-39del::		604124_[GENE=RBBP8_PHENOS=Seckel syndrome 2, 606744 (3), Autosomal recessive; Jawad syndrome, 251255 (3), Autosomal recessive; Pancreatic carcinoma, somatic (3)]	1263878 [benign DISEASE=not provided];			rs3052770		0.5689	21813,.	0.2077,0.5114,0.4647,0.6430,0.5451	-0.3020			0.33					0.0608	0.5028	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RBBP8 (inh=AR oe_syn=0.99 oe_mis=1.00 oe_lof=0.54)
chr18	51058485	51058485	-	T	het	off-target	QUAL=2171;DP=215;AF=0.16;MQM=60;SAP=4;ABP=215	SMAD4	intron	SMAD4:ENST00000342988.8:intron_variant:MODIFIER:intron7/11:c.904+45dup::,SMAD4:ENST00000398417.6:intron_variant:MODIFIER:intron7/11:c.904+45dup::,SMAD4:ENST00000588745.5:intron_variant:MODIFIER:intron4/7:c.667+3508dup::	SMAD4:NM_005359.6:intron_variant:MODIFIER:intron7/11:c.904+45dup::		600993_[GENE=SMAD4_PHENOS=Pancreatic cancer, somatic, 260350 (3); Myhre syndrome, 139210 (3), Autosomal dominant; Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant; Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3), Autosomal dominant]	492739 [benign DISEASE=not specified,not provided];			rs386387676		0.1673	105,.	0.1574,0.1563,0.1985,0.1708,0.1496				12.61				COSV61689656	0.0414	0.7737	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMAD4 (inh=AD oe_syn=0.93 oe_mis=0.34 oe_lof=0.07)
chr18	51058485	51058485	-	TT	het	off-target	QUAL=2171;DP=215;AF=0.38;MQM=60;SAP=11;ABP=31	SMAD4	intron	SMAD4:ENST00000342988.8:intron_variant:MODIFIER:intron7/11:c.904+44_904+45dup::,SMAD4:ENST00000398417.6:intron_variant:MODIFIER:intron7/11:c.904+44_904+45dup::,SMAD4:ENST00000588745.5:intron_variant:MODIFIER:intron4/7:c.667+3507_667+3508dup::	SMAD4:NM_005359.6:intron_variant:MODIFIER:intron7/11:c.904+44_904+45dup::		600993_[GENE=SMAD4_PHENOS=Pancreatic cancer, somatic, 260350 (3); Myhre syndrome, 139210 (3), Autosomal dominant; Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant; Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3), Autosomal dominant]	1227283 [benign DISEASE=not provided];			rs386387676		0.3348	7119,.	0.1110,0.2014,0.2348,0.1888,0.1415				12.56				COSV61689656	0.0797	0.7734	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMAD4 (inh=AD oe_syn=0.93 oe_mis=0.34 oe_lof=0.07)
chr19	17268749	17268749	C	T	het	off-target	QUAL=1316;DP=109;AF=0.48;MQM=60;SAP=6;ABP=4	BABAM1,	splice_region&intron,intron,intron&NMD_transcript	BABAM1:ENST00000359435.8:splice_region_variant&intron_variant:LOW:intron1/8:c.-51-7C>T::,BABAM1:ENST00000447614.6:intron_variant:MODIFIER:intron1/5:c.-13-45C>T::,BABAM1:ENST00000595632.5:splice_region_variant&intron_variant:LOW:intron1/5:c.-51-7C>T::,:ENST00000596542.1:intron_variant&NMD_transcript_variant:MODIFIER:intron1/9:c.-13-45C>T::,BABAM1:ENST00000598188.6:intron_variant:MODIFIER:intron1/8:c.-13-45C>T::,BABAM1:ENST00000601043.5:intron_variant:MODIFIER:intron1/8:c.-13-45C>T::	BABAM1:NM_001033549.3:splice_region_variant&intron_variant:LOW:intron1/8:c.-51-7C>T::,BABAM1:NM_001288756.2:intron_variant:MODIFIER:intron1/8:c.-13-45C>T::,BABAM1:NM_001288757.2:splice_region_variant&intron_variant:LOW:intron1/5:c.-51-7C>T::,BABAM1:NM_014173.4:intron_variant:MODIFIER:intron1/8:c.-13-45C>T::	regulatory_region_variant:promoter		1227766 [benign DISEASE=not provided];	CS1518199 [CLASS=DFP MUT=ALT PHEN="Breast cancer association with" GENE=BABAM1];		rs10424178	0.1727	0.2250	4469,.	0.3533,0.0925,0.0004,0.1919,0.1115	-0.3220			4.16		1.98>3.28	0.000/0.134		-0.1219	0.8748	0.25	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USHBP1 (inh=n/a oe_syn=0.93 oe_mis=1.02 oe_lof=0.79), BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07)
chr19	17271696	17271696	A	T	het	off-target	QUAL=331;DP=49;AF=0.37;MQM=60;SAP=3;ABP=10	BABAM1,	intron,intron&NMD_transcript	BABAM1:ENST00000359435.8:intron_variant:MODIFIER:intron3/8:c.344+41A>T::,BABAM1:ENST00000447614.6:intron_variant:MODIFIER:intron3/5:c.344+41A>T::,BABAM1:ENST00000595632.5:intron_variant:MODIFIER:intron3/5:c.344+41A>T::,:ENST00000596542.1:intron_variant&NMD_transcript_variant:MODIFIER:intron2/9:c.286-2208A>T::,BABAM1:ENST00000598188.6:intron_variant:MODIFIER:intron3/8:c.344+41A>T::,BABAM1:ENST00000601043.5:intron_variant:MODIFIER:intron3/8:c.344+41A>T::	BABAM1:NM_001033549.3:intron_variant:MODIFIER:intron3/8:c.344+41A>T::,BABAM1:NM_001288756.2:intron_variant:MODIFIER:intron3/8:c.344+41A>T::,BABAM1:NM_001288757.2:intron_variant:MODIFIER:intron3/5:c.344+41A>T::,BABAM1:NM_014173.4:intron_variant:MODIFIER:intron3/8:c.344+41A>T::						rs10420922	0.4631	0.4940	19690,.	0.6918,0.3280,0.3137,0.4338,0.3806	-0.5940			0.97				COSV63921517	0.043	0.1991	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07)
chr19	17276445	17276445	G	A	het	off-target	QUAL=1378;DP=101;AF=0.52;MQM=60;SAP=3;ABP=4	BABAM1,	intron,intron&NMD_transcript	BABAM1:ENST00000359435.8:intron_variant:MODIFIER:intron6/8:c.570-50G>A::,BABAM1:ENST00000447614.6:intron_variant:MODIFIER:intron3/5:c.345-50G>A::,BABAM1:ENST00000595632.5:intron_variant:MODIFIER:intron3/5:c.345-50G>A::,:ENST00000596542.1:intron_variant&NMD_transcript_variant:MODIFIER:intron5/9:c.*184-50G>A::,BABAM1:ENST00000598188.6:intron_variant:MODIFIER:intron6/8:c.570-50G>A::,BABAM1:ENST00000601043.5:intron_variant:MODIFIER:intron6/8:c.570-50G>A::	BABAM1:NM_001033549.3:intron_variant:MODIFIER:intron6/8:c.570-50G>A::,BABAM1:NM_001288756.2:intron_variant:MODIFIER:intron6/8:c.570-50G>A::,BABAM1:NM_001288757.2:intron_variant:MODIFIER:intron3/5:c.345-50G>A::,BABAM1:NM_014173.4:intron_variant:MODIFIER:intron6/8:c.570-50G>A::						rs61634114	0.0990	0.1596	2114,.	0.1450,0.0815,0.0007,0.1776,0.1166	0.6530			5.51					-0.4092	0.9558	0.23	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07)
chr19	17278839	17278839	C	T	het		QUAL=1232;DP=108;AF=0.47;MQM=60;SAP=3;ABP=4	BABAM1,	splice_region&intron,intron&NMD_transcript	BABAM1:ENST00000359435.8:splice_region_variant&intron_variant:LOW:intron8/8:c.787-6C>T::,BABAM1:ENST00000447614.6:splice_region_variant&intron_variant:LOW:intron5/5:c.562-6C>T::,BABAM1:ENST00000595632.5:splice_region_variant&intron_variant:LOW:intron5/5:c.562-6C>T::,:ENST00000596542.1:intron_variant&NMD_transcript_variant:MODIFIER:intron7/9:c.*400+1930C>T::,BABAM1:ENST00000598188.6:splice_region_variant&intron_variant:LOW:intron8/8:c.787-6C>T::,BABAM1:ENST00000601043.5:splice_region_variant&intron_variant:LOW:intron8/8:c.787-6C>T::	BABAM1:NM_001033549.3:splice_region_variant&intron_variant:LOW:intron8/8:c.787-6C>T::,BABAM1:NM_001288756.2:splice_region_variant&intron_variant:LOW:intron8/8:c.787-6C>T::,BABAM1:NM_001288757.2:splice_region_variant&intron_variant:LOW:intron5/5:c.562-6C>T::,BABAM1:NM_014173.4:splice_region_variant&intron_variant:LOW:intron8/8:c.787-6C>T::	regulatory_region_variant:enhancer					rs10406920	0.1118	0.1716	2411,.	0.1828,0.0790,0.0006,0.1783,0.1144	0.7980			1.96		8.04>7.99	0.000/0.002	COSV63921267	-0.5749	0.9948	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07), ANKLE1 (inh=n/a oe_syn=0.91 oe_mis=0.87 oe_lof=1.04)
chr19	17278895	17278895	G	A	het		QUAL=6312;DP=539;AF=0.47;MQM=60;SAP=3;ABP=7	BABAM1,	synonymous,intron&NMD_transcript	BABAM1:ENST00000359435.8:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279=:,BABAM1:ENST00000447614.6:synonymous_variant:LOW:exon6/6:c.612G>A:p.Lys204=:,BABAM1:ENST00000595632.5:synonymous_variant:LOW:exon6/6:c.612G>A:p.Lys204=:,:ENST00000596542.1:intron_variant&NMD_transcript_variant:MODIFIER:intron7/9:c.*400+1986G>A::,BABAM1:ENST00000598188.6:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279=:,BABAM1:ENST00000601043.5:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279=:	BABAM1:NM_001033549.3:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279=:,BABAM1:NM_001288756.2:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279=:,BABAM1:NM_001288757.2:synonymous_variant:LOW:exon6/6:c.612G>A:p.Lys204=:,BABAM1:NM_014173.4:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279=:	regulatory_region_variant:enhancer			CM1010189 [CLASS=DP MUT=ALT PHEN="Ovarian cancer susceptibility to" GENE=BABAM1];		rs8170	0.1124	0.1735	2466,.	0.1918,0.0800,0.0006,0.1795,0.1147	3.0590			10.27				COSV63920809	-0.0872	0.9214	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07), ANKLE1 (inh=n/a oe_syn=0.91 oe_mis=0.87 oe_lof=1.04)
chr20	14186637	14186637	A	G	hom		QUAL=905;DP=31;AF=1.00;MQM=60;SAP=4;ABP=0	MACROD2	intron	MACROD2:ENST00000217246.8:intron_variant:MODIFIER:intron3/16:c.271+100909A>G::,MACROD2:ENST00000642719.1:intron_variant:MODIFIER:intron3/17:c.271+100909A>G::,MACROD2:ENST00000684519.1:intron_variant:MODIFIER:intron3/17:c.271+100909A>G::	MACROD2:NM_001351661.2:intron_variant:MODIFIER:intron3/17:c.271+100909A>G::,MACROD2:NM_001351663.2:intron_variant:MODIFIER:intron3/17:c.271+100909A>G::,MACROD2:NM_080676.6:intron_variant:MODIFIER:intron3/16:c.271+100909A>G::					L1PA16 (LINE/L1)	rs6074704	0.4792	0.5259	22712,.		-0.5390			9.31							0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MACROD2 (inh=n/a oe_syn=0.89 oe_mis=0.87 oe_lof=0.22)
chr20	49684609	49684609	G	A	hom		QUAL=39631;DP=1210;AF=1.00;MQM=60;SAP=5;ABP=0	B4GALT5	intron	B4GALT5:ENST00000371711.4:intron_variant:MODIFIER:intron1/8:c.116-27907C>T::	B4GALT5:NM_004776.4:intron_variant:MODIFIER:intron1/8:c.116-27907C>T::						rs6512586	0.4681	0.5178	18677,.	0.3755,0.4483,0.3696,0.5460,0.6515	-0.9890			0.26				COSV65493865			0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					B4GALT5 (inh=n/a oe_syn=0.97 oe_mis=0.56 oe_lof=0.00)
